FedInvent™ Patent Applications

Application Details for Thursday, January 20, 2022 

This page was updated on Saturday, January 22, 2022 at 01:04 AM GMT

Department of Health and Human Services (HHS) 

US 20220015363 Gitai et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Trustees of Princeton University (Princeton, New Jersey)
ASSIGNEE(S) The Trustees of Princeton University (Princeton, New Jersey)
INVENTOR(S) Zemer Gitai (Princeton, New Jersey);  Robert J. Scheffler (Baltimore, Maryland);  Mohamed Abou Donia (Princeton, New Jersey);  Yuki Sugimoto (Cambridge, Massachusetts)
ABSTRACT A system and method for dispersing pathogens having Type IV pili that are surface-attached to a surface or preventing pathogens from surface-attaching to a surface, using a certain quinolone compounds (such as 2-methyl-4-hydroxyquinolone (MHQ)) as dispersing agents.
FILED Monday, July 12, 2021
APPL NO 17/372952
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/04 (20130101)
A01N 43/42 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220015832 DiMaio et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
National Science Foundation (NSF)
APPLICANT(S) Intuitive Surgical Operations, Inc. (Sunnyvale, California);  The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Simon P. DiMaio (San Carlos, California);  Christopher J. Hasser (Los Altos, California);  Russell H. Taylor (Severna Park, Maryland);  David Q. Larkin (Menlo Park, California);  Peter Kazanzides (Towson, Maryland);  Anton Deguet (Baltimore, Maryland);  Balazs Peter Vagvolgyi (Baltimore, Maryland);  Joshua Leven (San Francisco, California)
ABSTRACT A minimally invasive surgical system is disclosed including a processor coupled to a stereoscopic endoscope and a stereoscopic video display device. The processor generates an operative image of an anatomic structure in the surgical site, overlays the operative image onto the captured stereo video images for display on the stereoscopic video display device, generates and overlays a pointer onto the operative image or the captured stereo video images to display the pointer on the stereoscopic video display device with a three dimensional appearance, and switches between a first mode for input devices of a surgeon console used to couple motion into surgical instruments and a second mode used to control an interactive graphical user interface to allow interactions with the pointer and the operative image in three dimensions using input devices having at least three degrees of freedom.
FILED Tuesday, September 07, 2021
APPL NO 17/468198
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 1/00193 (20130101)
A61B 8/00 (20130101)
A61B 8/12 (20130101)
A61B 8/4245 (20130101)
A61B 34/10 (20160201) Original (OR) Class
A61B 34/30 (20160201)
A61B 34/37 (20160201)
A61B 34/70 (20160201)
A61B 34/71 (20160201)
A61B 34/76 (20160201)
A61B 2017/00203 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016051 LOPACHIN et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) MONTEFIORE MEDICAL CENTER (Bronx, New York)
ASSIGNEE(S) MONTEFIORE MEDICAL CENTER (Bronx, New York)
INVENTOR(S) Richard LOPACHIN (New York, New York);  Brian C. GEOHEGAN (New York, New York)
ABSTRACT Methods and compositions are disclosed for reducing neuropathy or ototoxicity associated with chemotherapeutic agents by administering one or more enol compounds to a subject.
FILED Friday, December 27, 2019
APPL NO 17/309702
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/12 (20130101)
A61K 31/122 (20130101) Original (OR) Class
A61K 31/167 (20130101)
A61K 31/282 (20130101)
A61K 33/243 (20190101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/28 (20180101)
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016056 GURTNER et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California)
ASSIGNEE(S)
INVENTOR(S) Geoffrey C. GURTNER (Portola Valley, California);  Jayakumar RAJADAS (Cupertino, California);  Michael Gabriel GALVEZ (Palo Alto, California);  Evgenios NEOFYTOU (Stanford, California)
ABSTRACT Compositions and methods are provided for the prevention and treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent that increases activity of HIF-1α in the wound.
FILED Tuesday, September 28, 2021
APPL NO 17/487856
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/06 (20130101)
A61K 9/0014 (20130101)
A61K 9/1075 (20130101)
A61K 9/7023 (20130101)
A61K 9/7053 (20130101)
A61K 9/7069 (20130101)
A61K 31/16 (20130101) Original (OR) Class
A61K 47/26 (20130101)
A61K 47/32 (20130101)
A61K 47/38 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016063 VIDYASAGAR et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) UNIVERSITY OF FLORDIA RESEARCH FOUNDATION, INCORPORATED (Gainesville, Florida)
ASSIGNEE(S)
INVENTOR(S) Sadasivan VIDYASAGAR (Gainesville, Florida);  James COLLINS (Gainesville, Florida);  Regina WOLOSHUN (Gainesville, Florida)
ABSTRACT Amino acid compositions useful for increasing the amount of the divalent metal-ion transporter 1, DMT1 (encoded by the gene SLC11A2), on the duodenal bmsh border membrane (BBM) are described herein. Methods for increasing the concentration of DMT1 on the duodenal BBM (on trafficking) and increasing iron uptake are also presented. Compositions and methods described herein are useful for treating a disorder or disease associated with iron deficiency in subjects afflicted with such disorders or diseases. Use of these compositions for the treatment of disorders or diseases associated with iron deficiency and in the preparation of a medicament for the treatment of disorders or diseases associated with iron deficiency are also encompassed herein.
FILED Friday, December 06, 2019
APPL NO 17/311234
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/198 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 7/06 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016075 Baker et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) University of South Florida (Tampa, Florida)
ASSIGNEE(S)
INVENTOR(S) Bill J. Baker (Temple Terrace, Florida);  Kyle Rohde (Orlando, Florida);  Bingjie Yang (Temple Terrace, Florida);  Marisa Fuse (Winter Springs, Florida)
ABSTRACT The present disclosure provides methods for the treatment of infections with Mycobacterium such as tuberculosis or leprosy.
FILED Wednesday, July 14, 2021
APPL NO 17/375403
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/12 (20130101)
A61K 31/44 (20130101)
A61K 31/133 (20130101)
A61K 31/145 (20130101)
A61K 31/192 (20130101)
A61K 31/235 (20130101)
A61K 31/343 (20130101)
A61K 31/352 (20130101)
A61K 31/365 (20130101)
A61K 31/366 (20130101) Original (OR) Class
A61K 31/454 (20130101)
A61K 31/472 (20130101)
A61K 31/496 (20130101)
A61K 31/498 (20130101)
A61K 31/505 (20130101)
A61K 31/4015 (20130101)
A61K 31/4045 (20130101)
A61K 31/4409 (20130101)
A61K 31/7036 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/06 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016100 Edge et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) Massachusetts Eye and Ear Infirmary (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Albert Edge (Brookline, Massachusetts);  Yenfu Cheng (Boston, Massachusetts)
ABSTRACT Methods for treating hearing loss that include administering an inhibitor, e.g., a small molecule inhibitor, of casein kinase 1, preferably in combination with a treatment that stimulates Atoh1 gene expression, e.g., a gamma-secretase inhibitor, an Atoh1 stimulatory compound, or a GSK-3-beta inhibitor.
FILED Friday, October 08, 2021
APPL NO 17/450377
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0046 (20130101)
A61K 31/437 (20130101)
A61K 31/4439 (20130101) Original (OR) Class
A61K 38/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 27/16 (20180101)

Heterocyclic Compounds
C07D 401/04 (20130101)
C07D 403/04 (20130101)
C07D 405/14 (20130101)
C07D 413/14 (20130101)
C07D 487/04 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/485 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 2800/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016106 Sykes et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) THE BROAD INSTITUTE, INC. (CAMBRIDGE, Massachusetts);  THE GENERAL HOSPITAL CORPORATION (BOSTON, Massachusetts);  PRESIDENT AND FELLOWS OF HARVARD COLLEGE (CAMBRIDGE, Massachusetts);  BAYER PHARMA AKTIENGESELLSCHAFT (BERLIN, Germany)
ASSIGNEE(S) THE BROAD INSTITUTE, INC. (CAMBRIDGE, Massachusetts);  THE GENERAL HOSPITAL CORPORATION (BOSTON, Massachusetts);  PRESIDENT AND FELLOWS OF HARVARD COLLEGE (CAMBRIDGE, Massachusetts);  BAYER PHARMA AKTIENGESELLSCHAFT (BERLIN, Germany)
INVENTOR(S) David B. Sykes (Boston, Massachusetts);  David Scadden (Boston, Massachusetts);  Timothy A. Lewis (Cambridge, Massachusetts);  Andreas Janzer (Berlin, Germany);  Hanna Meyer (Berlin, Germany);  Detlef Stöckigt (Potsdam, Germany)
ABSTRACT The present invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes with DHODH inhibitors, such as 6-fluoro-2-(2′-fluoro-[1,1′-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid).
FILED Thursday, July 22, 2021
APPL NO 17/383161
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/27 (20130101)
A61K 31/42 (20130101)
A61K 31/47 (20130101) Original (OR) Class
A61K 31/277 (20130101)
A61K 31/505 (20130101)
A61K 33/36 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/02 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016130 Huang
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Haojie Huang (Rochester, Minnesota)
ABSTRACT This document provides methods and materials involved in identifying and treating mammals having a cancer resistant to BET inhibitors. For example, methods and materials for administering (a) one or more AKT inhibitors and/or one or more CDK inhibitors and/or one or more CBP/p300 inhibitors in combination with (b) one or more BET inhibitors to mammals identified as having a cancer resistant to treatment with one or more BET inhibitors in the absence of AKT, CDK, and CBP/p300 inhibitors are provided.
FILED Thursday, July 25, 2019
APPL NO 17/263010
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/551 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016131 Mitra et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
APPLICANT(S) Robi Mitra (St. Louis, Missouri);  Arnav Moudgil (St. Louis, Missouri);  Michael Nathaniel Wilkinson (St. Louis, Missouri)
ASSIGNEE(S) Washington University (St. Louis, Missouri)
INVENTOR(S) Robi Mitra (St. Louis, Missouri);  Arnav Moudgil (St. Louis, Missouri);  Michael Nathaniel Wilkinson (St. Louis, Missouri)
ABSTRACT Among the various aspects of the present disclosure is the provision of a methods for increasing chemotherapy sensitivity or decreasing chemotherapy resistance using BET inhibitors.
FILED Friday, July 09, 2021
APPL NO 17/371750
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/506 (20130101)
A61K 31/551 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016135 Ince
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) UNIVERSITY OF MIAMI (Miami, Florida)
ASSIGNEE(S)
INVENTOR(S) Tan Ince (Miami, Florida)
ABSTRACT The invention provides a classification and treatment system for breast cancer using measurements of and ligands for estrogen receptor, androgen receptor, vitamin D receptor, and optionally HER2 receptor.
FILED Thursday, July 16, 2020
APPL NO 16/931303
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/167 (20130101)
A61K 31/337 (20130101)
A61K 31/517 (20130101)
A61K 31/565 (20130101)
A61K 31/567 (20130101)
A61K 31/593 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016138 Devlin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) President and Fellows of Flarvard College (Cambridge, Massachusetts);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
INVENTOR(S) Abigail Sloan Devlin (Cambridge, Massachusetts);  Snehal N. Chaudhari (Cambridge, Massachusetts);  Eric Garland Sheu (Brookline, Massachusetts);  David A. Harris (Arlington, Massachusetts);  Jinbo Lee (Cambridge, Massachusetts)
ABSTRACT The compositions and methods provided herein are related, in part, to the discovery of cholic acid 7-sulfate as a treatment for diabetes. Provided herein is a method for treating a metabolic disorder (e.g., diabetes, obesity), or an inflammatory disease (e.g., Crohn's disease, inflammatory bowel disease, ulcerative colitis, pancreatitis, hepatitis, appendicitis, gastritis, diverticulitis, celiac disease, food intolerance, enteritis, ulcer, gastroesophageal reflux disease (GERD), psoriatic arthritis, psoriasis, and rheumatoid arthritis) in a subject in need thereof comprising administering to a subject a compound of Formulae (I)-(XVII).
FILED Wednesday, December 04, 2019
APPL NO 17/309520
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/575 (20130101)
A61K 31/664 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 3/04 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016139 Heneine et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human (Bethesda, Maryland)
ASSIGNEE(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human (Bethesda, Maryland)
INVENTOR(S) Walid Heneine (Atlanta, Georgia);  Thomas M. Folks (Helotes, Texas);  Robert Janssen (Atlanta, Georgia);  Ronald A. Otten (Villa Rica, Georgia);  Jose Gerardo Garcia Lerma (Decatur, Georgia)
ABSTRACT A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host. A process for controlling retrovirus transmission within a population includes the administration to a subpopulation at high risk for contracting an immunodeficiency retroviral infection the detailed combination prior to sexual exposure to a source of immunodeficiency retrovirus so as to preclude the immunodeficiency retrovirus from becoming self-replicating in a member of the subpopulation.
FILED Friday, February 26, 2021
APPL NO 17/186534
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0034 (20130101)
A61K 9/0053 (20130101)
A61K 31/513 (20130101)
A61K 31/675 (20130101) Original (OR) Class
A61K 31/683 (20130101)
A61K 31/7072 (20130101)
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016140 Heneine et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic (Bethesda, Maryland)
ASSIGNEE(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic (Bethesda, Maryland)
INVENTOR(S) Walid Heneine (Atlanta, Georgia);  Thomas M. Folks (Helotes, Texas);  Robert Janssen (Atlanta, Georgia);  Ronald A. Otten (Villa Rica, Georgia);  Jose Gerardo Garcia Lerma (Decatur, Georgia)
ABSTRACT A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host. A process for controlling retrovirus transmission within a population includes the administration to a subpopulation at high risk for contracting an immunodeficiency retroviral infection the detailed combination prior to sexual exposure to a source of immunodeficiency retrovirus so as to preclude the immunodeficiency retrovirus from becoming self-replicating in a member of the subpopulation.
FILED Friday, February 26, 2021
APPL NO 17/186559
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0034 (20130101)
A61K 9/0053 (20130101)
A61K 31/513 (20130101)
A61K 31/675 (20130101) Original (OR) Class
A61K 31/683 (20130101)
A61K 31/7072 (20130101)
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016141 Heneine et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human (Bethesda, Maryland)
ASSIGNEE(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human (Bethesda, Maryland)
INVENTOR(S) Walid Heneine (Atlanta, Georgia);  Thomas M. Folks (Helotes, Texas);  Robert Janssen (Atlanta, Georgia);  Ronald A. Otten (Villa Rica, Georgia);  Jose Gerardo Garcia Lerma (Decatur, Georgia)
ABSTRACT A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host. A process for controlling retrovirus transmission within a population includes the administration to a subpopulation at high risk for contracting an immunodeficiency retroviral infection the detailed combination prior to sexual exposure to a source of immunodeficiency retrovirus so as to preclude the immunodeficiency retrovirus from becoming self-replicating in a member of the subpopulation.
FILED Friday, February 26, 2021
APPL NO 17/186583
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0034 (20130101)
A61K 9/0053 (20130101)
A61K 31/513 (20130101)
A61K 31/675 (20130101) Original (OR) Class
A61K 31/683 (20130101)
A61K 31/7072 (20130101)
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016148 Burridge
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Paul W. Burridge (Chicago, Illinois)
ABSTRACT Disclosed are methods, pharmaceutical compositions, kits, and systems for treating or preventing cardiotoxicity in a subject undergoing treatment with an anthracycline chemotherapeutic agent. The methods, pharmaceutical compositions, kits, and systems typically include or utilize an agonist of the retinoic acid receptor gamma (RARG).
FILED Monday, October 04, 2021
APPL NO 17/493571
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/192 (20130101)
A61K 31/196 (20130101)
A61K 31/381 (20130101)
A61K 31/415 (20130101)
A61K 31/704 (20130101) Original (OR) Class
A61K 31/4436 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 9/00 (20180101)
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016153 PAINTER et al.
FUNDED BY
Department of Defense (DOD)
Defense Threat Reduction Agency (DTRA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Centers of Excellence for Influenza Research and Surveillance (CEIRS)
APPLICANT(S) EMORY UNIVERSITY (Atlanta, Georgia)
ASSIGNEE(S)
INVENTOR(S) George R. PAINTER (Atlanta, Georgia);  Gregory R. Bluemling (Decatur, Georgia);  Michael G. Natchus (Alpharetta, Georgia);  David Guthrie (Avondale Estates, Georgia)
ABSTRACT This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.
FILED Thursday, September 02, 2021
APPL NO 17/465344
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7068 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/12 (20180101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 19/067 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016170 Sadelain et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
ASSIGNEE(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
INVENTOR(S) Michel Sadelain (New York, New York);  Matthias Stephan (Boston, Massachusetts)
ABSTRACT The present invention provides immunoresponsive cells, including T cells, cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells, expressing at least one of an antigen-recognizing receptor and a co-stimulatory ligand and methods of use therefore for the treatment of neoplasia and other pathologies where an increase in an antigen-specific immune response is desired.
FILED Wednesday, July 21, 2021
APPL NO 17/381587
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101) Original (OR) Class
A61K 38/217 (20130101)
A61K 38/2013 (20130101)
A61K 39/0011 (20130101)
A61K 45/06 (20130101)
A61K 2035/122 (20130101)
A61K 2039/5156 (20130101)
A61K 2039/5158 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)
C12N 7/00 (20130101)
C12N 15/85 (20130101)
C12N 2501/25 (20130101)
C12N 2501/51 (20130101)
C12N 2501/599 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016175 Shen
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S)
INVENTOR(S) Hua Shen (St. Louis, Missouri)
ABSTRACT Disclosed herein are bionanoparticles of adipose-derived stem cell extracellular vesicles, a tissue repair matrix comprising the bionanoparticles, and methods of use thereof for enhanced tendon healing.
FILED Friday, November 15, 2019
APPL NO 17/294006
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/28 (20130101) Original (OR) Class

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/3834 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0667 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016191 Weiss et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Ron Weiss (Newton, Massachusetts);  Jin Huh (Watertown, Massachusetts);  Yingzhong Li (Quincy, Massachusetts)
ABSTRACT Disclosed herein are genetically modified herpesviruses for the treatment of cancer. Also provided are methods of treating cancer using genetically modified herpesviruses.
FILED Friday, May 14, 2021
APPL NO 17/320965
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/763 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2710/16632 (20130101)
C12N 2710/16643 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016199 RADISIC et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Quthero, Inc. (Miami, Florida)
ASSIGNEE(S)
INVENTOR(S) Milica RADISIC (Toronto, Canada);  Yun XIAO (Toronto, Canada);  Lewis REIS (Toronto, Canada);  Serena MANDLA (Toronto, Canada)
ABSTRACT The invention provides a composition and pharmaceutical formulation including a peptide immobilized in a hydro gel. Compositions and formulations of the invention are useful in reducing the size, severity or duration of a wound, ameliorating of one or more symptoms associated with a wound without necessarily curing the wound, or lessening in the growth or severity of a wound. Compositions and formulations of the invention are particularly useful in the treatment of a wound associated with diabetes, such as a diabetic ulcer.
FILED Thursday, February 25, 2021
APPL NO 17/184745
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/7084 (20130101)
A61K 38/08 (20130101) Original (OR) Class
A61K 47/6903 (20170801)
A61K 47/6953 (20170801)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/44 (20130101)
A61L 26/008 (20130101)
A61L 26/0066 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 17/02 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016203 Weeraratna
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Wistar Institute of Anatomy and Biology (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Ashani T. Weeraratna (Merion Station, Pennsylvania)
ABSTRACT Compositions and methods for the prevention or reduction of metastasis are provided. Such compositions and methods include increasing the level or expression of HAPLN 1.
FILED Wednesday, October 02, 2019
APPL NO 17/281796
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/1709 (20130101) Original (OR) Class
A61K 48/005 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/04 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2740/15032 (20130101)
C12N 2740/15043 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5743 (20130101)
G01N 33/6887 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016206 TING et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Kang TING (Beverly Hills, California);  B. Chia SOO (Beverly Hills, California)
ABSTRACT This application is drawn to a method of using an isoform NELL-1 peptide, and compositions thereof for bone formation or for treating, preventing, or ameliorating osteoporosis.
FILED Monday, May 10, 2021
APPL NO 17/315593
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/32 (20130101)
A61K 38/1709 (20130101) Original (OR) Class

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 37/0092 (20130101)
A61M 2037/0007 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/303 (20130101)

Peptides
C07K 14/47 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016224 Wyss-Coray et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Anton Wyss-Coray (Palo Alto, California);  Joseph M. Castellano (Tuckahoe, New York)
ABSTRACT Methods of treating an adult mammal for an aging-associated condition are provided. Aspects of the methods include enhancing a TIMP activity, e.g., a TIMP2 activity, in the mammal in a manner sufficient to treat the adult mammal for the aging-associated condition. Also provided are compositions for use in practicing methods of the invention. A variety of aging-associated conditions may be treated by practice of the methods, which conditions include cognitive impairments.
FILED Friday, October 08, 2021
APPL NO 17/496986
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/55 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/28 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016241 Balu-Iyer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Research Foundation for The State University of New York (Amherst, New York)
ASSIGNEE(S)
INVENTOR(S) Sathy Balu-Iyer (Amherst, New York);  Matthew Pierson Kosloski (Wilmette, Illinois);  Krithika Arun Shetty (Buffalo, New York);  Jennifer Leigh Schneider (Buffalo, New York);  Anas M. Fathallah (San Diego, California)
ABSTRACT Provided are methods for inducing immune tolerance to antigens including therapeutic antigens. The present methods comprise administering to an individual OPLS or other lipidic compositions and the antigen, either in a single formulation or as separate formulations where the separate formulations are administered concomitantly or sequentially.
FILED Tuesday, July 27, 2021
APPL NO 17/443562
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/15 (20130101)
A61K 39/39 (20130101) Original (OR) Class
A61K 2039/54 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 37/02 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016250 SCHNEIDER et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Joel SCHNEIDER (Frederick, Maryland);  Poulami MAJUMDER (Frederick, Maryland);  Giorgio RAIMONDI (Sevenma, Maryland)
ASSIGNEE(S)
INVENTOR(S) Joel P. SCHNEIDER (Frederick, Maryland);  Poulami MAJUMDER (Frederick, Maryland);  Giorgio RAIMONDI (Severna Park, Maryland)
ABSTRACT Compositions that include a cationic peptide hydrogel and an immunosuppressive small molecule drug are described. The small molecule drug is crystallized and dispersed in the peptide hydrogel to allow for slow release of the drug. Methods of inhibiting allograft rejection and treating autoimmune-mediated organ damage by local administration of the peptide hydrogel compositions are described.
FILED Friday, May 03, 2019
APPL NO 17/051574
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/519 (20130101)
A61K 47/20 (20130101)
A61K 47/42 (20130101) Original (OR) Class
A61K 47/6903 (20170801)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 37/06 (20180101)

Peptides
C07K 14/001 (20130101)
C07K 14/70503 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016267 HABER et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) CITY OF HOPE (Duarte, California)
ASSIGNEE(S)
INVENTOR(S) Tom HABER (Pasadena, California);  Pengpeng CAO (Duarte, California);  Jacob BERLIN (Monrovia, California);  Karen ABOODY (Arcadia, California)
ABSTRACT Disclosed herein, inter alia, are methods for detecting cancer using nanoparticles.
FILED Monday, August 23, 2021
APPL NO 17/408972
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 49/005 (20130101) Original (OR) Class
A61K 49/0017 (20130101)
A61K 49/0093 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016271 Farokhzad et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Brigham and Women`s Hospital, Inc. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Omid C. Farokhzad (Waban, Massachusetts);  Na Kong (Boston, Massachusetts);  Jinjun Shi (Boston, Massachusetts);  Wei Tao (Brookline, Massachusetts)
ABSTRACT The present application provides a method of treating a cancer, including administering to a subject in need of cancer treatment a therapeutically effective amount of an mRNA encoding tumor suppressor protein p53 in combination with an anticancer therapeutic agent, or a pharmaceutically acceptable salt thereof, wherein the anticancer therapeutic agent is selected from an mTOR inhibitor, a platinum-based antineoplastic agent, and an AMPK activating agent.
FILED Wednesday, December 11, 2019
APPL NO 17/413061
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/155 (20130101)
A61K 31/436 (20130101)
A61K 33/243 (20190101)
A61K 38/1758 (20130101)
A61K 51/0408 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016277 Babich et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
APPLICANT(S) Cornell University (Ithaca, New York)
ASSIGNEE(S) Cornell University (Ithaca, New York)
INVENTOR(S) John W. Babich (New York, New York);  Justin WILSON (Ithaca, New York);  Nikki THIELE (Kingston, Tennessee);  James M. Kelly (New York, New York);  Shashikanth Ponnala (New York, New York)
ABSTRACT The present technology provides compounds as well as compositions including such compounds useful in targeted radiotherapy of cancer and/or mammalian tissue overexpressing prostate specific membrane antigen (“PSMA”) where the compounds are represented by the following Formulas (I), or a pharmaceutically acceptable salt thereof (IA), or a pharmaceutically acceptable salt thereof (II), or a pharmaceutically acceptable salt thereof, wherein M1 is independently at each occurrence an alpha-emitting radionuclide. Equivalents of such compounds are also disclosed.
FILED Wednesday, November 20, 2019
APPL NO 17/294375
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 51/0482 (20130101)
A61K 51/1072 (20130101) Original (OR) Class

Heterocyclic Compounds
C07D 413/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016316 BITAR
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Wake Forest University Health Sciences (Winston-Salem, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Khalil BITAR (Winston-Salem, North Carolina)
ABSTRACT The present disclosure provides methods of bioengineering sphincters having autologous smooth muscle cells isolated from human internal anal sphincter and autologous enteric neurospheres (neural progenitor cells) isolated from human small intestine (jejunum). The isolated neural progenitor cells and smooth muscle cells are co -cultured using dual layered hydrogels and allowed to form circular, intrinsically innervated internal anal sphincter constructs. Such innervated internal anal sphincter constructs, bioengineered internal anal sphincter constructs are useful as additive implants in the treatment of fecal incontinence.
FILED Thursday, November 14, 2019
APPL NO 17/294312
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 10/04 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/367 (20130101) Original (OR) Class
A61L 27/3629 (20130101)
A61L 27/3687 (20130101)
A61L 27/3691 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0697 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016318 Maninishkis et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) THE UNITED STATE OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARMENT OF HEALTH AND HUMAN SERVICE (Bethesda, Maryland)
ASSIGNEE(S) THE UNITED STATE OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARMENT OF HEALTH AND HUMAN SERVICES (Bethesda, Maryland)
INVENTOR(S) Arvydas Maninishkis (Washington, District of Columbia);  Kapil Bharti (Potomac, Maryland)
ABSTRACT Tissue replacement implants are disclosed that include polarized retinal pigment epithelial cells on a polylactic-co-glycolic acid) (PLGA) scaffold, wherein the PLGA scaffold is 20-30 microns in thickness, has a DL-lactide/glycotide ratio of about 1:1, an average pore size of less than about 1 micron, and a fiber diameter of about 150 to about 650 nm. Also disclosed are methods of treating a subject with a retinal degenerative disease, retinal or retinal pigment epithelium dysfunction, retinal degradation, retinal damage, or loss of retinal pigment epithelium. These methods include locally administering to the eye of the subject the tissue replacement implant. In further embodiments, methods are disclosed for producing the tissue replacement implant.
FILED Monday, November 18, 2019
APPL NO 17/295030
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/18 (20130101)
A61L 27/54 (20130101)
A61L 27/56 (20130101)
A61L 27/3813 (20130101) Original (OR) Class
A61L 27/3834 (20130101)
A61L 27/3869 (20130101)
A61L 2430/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016420 Lo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Yi-Kai Lo (Los Angeles, California);  Wentai Liu (Los Angeles, California);  Victor R. Edgerton (Los Angeles, California);  Chih-Wei Chang (Los Angeles, California)
ABSTRACT A wireless implant and associated system for motor function recovery after spinal cord injury, and more particularly a multi-channel wireless implant with small package size. The wireless implant can further be used in various medical applications, such as retinal prostheses, gastrointestinal implant, vagus nerve stimulation, and cortical neuromodulation. The system also includes a method and its implementation to acquire the impedance model of the electrode-tissue interface of the implant.
FILED Friday, August 27, 2021
APPL NO 17/459483
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/08 (20130101)
A61N 1/0551 (20130101)
A61N 1/3787 (20130101)
A61N 1/36003 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016424 Ayata et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE GENERAL HOSPITAL CORPORATION (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Cenk Ayata (Sudbury, Massachusetts);  Aman B. Patel (Cambridge, Massachusetts)
ABSTRACT A system and method is provided for improving the patient outcome for a subject having an aneurysm. The method includes determining that the subject has the aneurysm, positioning a vagus nerve stimulation system on the subject, the vagus nerve stimulation system being configured to provide an electrical stimulation to the vagus nerve of the subject. Stimulating the vagus nerve of the subject with the vagus nerve stimulation system to at least one of: prevent further growth of the aneurysm; decrease the likelihood that the aneurysm ruptures; and decrease effects of rupture, when the aneurysm of the subject ruptures.
FILED Wednesday, November 20, 2019
APPL NO 17/295099
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/0456 (20130101)
A61N 1/36034 (20170801) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016434 IVRY et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (OAKLAND, California)
ASSIGNEE(S)
INVENTOR(S) RICHARD IRWIN IVRY (El Cerrito, California);  DANIEL J. SHELTRAW (Albany, California);  LUDOVICA LABRUNA (Kensington, California);  BENJAMIN A. INGLIS (Lafayette, California)
ABSTRACT A magnetic stimulation system includes a magnetic coil to generate an electric field of a magnitude having a desired effect on a brain, a voltage to current source to generate a current waveform having an amplitude and frequency to produce the electric field, and a controller to control the voltage to current source and to apply the current to the magnetic coil to provide perturbation of brain tissue using one or more periods of either continuously induced electric field with constant amplitude and frequency, or periods of electric field with at least one of amplitude and frequency modulation. A method of magnetically stimulating a brain includes placing a coil near a brain, and applying a current having an amplitude and frequency to the coil to produce an electric field having a desired effect on the brain, wherein the amplitude and frequency are applied using one of either one or more periods of continuously induced electric fields with constant amplitude and frequency, or periods of an electric field with at least one of either amplitude and frequency modulation.
FILED Wednesday, November 27, 2019
APPL NO 17/311596
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 2/02 (20130101)
A61N 2/006 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016612 Zhao
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Iowa State University Research Foundation, Inc. (Ames, Iowa)
ASSIGNEE(S)
INVENTOR(S) Yan Zhao (Ames, Iowa)
ABSTRACT The disclosure relates to molecularly-imprinted cross-linked micelles that can selectively hydrolyze carbohydrates.
FILED Tuesday, July 06, 2021
APPL NO 17/368257
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/067 (20130101) Original (OR) Class
B01J 35/0013 (20130101)
B01J 37/04 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 1/00 (20130101)

Polysaccharides; Derivatives Thereof
C08B 15/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016613 Betley et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Theodore Alexander Betley (Cambridge, Massachusetts);  Alexandre Mikhailine (Cambridge, Massachusetts);  Claudia Kleinlein (Cambridge, Massachusetts);  Yuyang Dong (Cambridge, Massachusetts);  Yunjung Baek (Cambridge, Massachusetts)
ABSTRACT Disclosed are compounds, methods, reagents, systems, and kits for the preparation and utilization of monomeric or polymeric metal-based compounds. These metal-based compounds are organometallic catalysts composed of substituted dipyrrin ligands bound to transition metals. C—H bond functionalization catalysis can be performed with the disclosed organometallic catalysts to yield C—N bonds to generate substituted bicyclic, spiro, and fused nitrogen-containing heterocycles, all common motifs in various pharmaceutical and bioactive molecules.
FILED Thursday, September 19, 2019
APPL NO 17/276855
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/1815 (20130101) Original (OR) Class
B01J 31/2243 (20130101)
B01J 2231/4283 (20130101)
B01J 2531/0216 (20130101)
B01J 2531/842 (20130101)
B01J 2531/845 (20130101)
B01J 2531/847 (20130101)
B01J 2540/66 (20130101)

Heterocyclic Compounds
C07D 207/06 (20130101)
C07D 209/04 (20130101)
C07D 209/44 (20130101)
C07D 209/54 (20130101)
C07D 211/70 (20130101)
C07D 263/04 (20130101)
C07D 401/04 (20130101)
C07D 403/04 (20130101)
C07D 471/04 (20130101)
C07D 471/08 (20130101)
C07D 487/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016617 Mendoza et al.
FUNDED BY
Department of Health and Human Services (HHS)
Assistant Secretary for Preparedness and Response (ASPR)
Biomedical Advanced Research and Development Authority (BARDA)
APPLICANT(S) SRI International (Menlo Park, California)
ASSIGNEE(S)
INVENTOR(S) Estevan Mendoza (Mountain View, California);  Eric Warner (Oceanside, California)
ABSTRACT Embodiments in accordance with the present disclosure are directed to sample collecting and dispensing methods and apparatuses. An example apparatus includes a capillary sampler disposed on a device first end, wherein the capillary sampler is configured to collect a fluid sample via an opening and a capillary body. The apparatus further includes a reagents chamber in fluid communication with the capillary sampler, and a barrier assembly disposed between the capillary sampler and the reagents chamber, wherein the barrier assembly is configured to separate fluid in the reagents chamber from the capillary sampler. A plunger assembly disposed on a device second end opposite the device first end, may modify the barrier assembly to dispense the fluid from the reagents chamber to the capillary sampler responsive to application of a force in the direction of the device first end.
FILED Wednesday, August 21, 2019
APPL NO 17/295195
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/022 (20130101) Original (OR) Class
B01L 3/502 (20130101)
B01L 2200/16 (20130101)
B01L 2200/026 (20130101)
B01L 2200/0684 (20130101)
B01L 2300/14 (20130101)
B01L 2300/044 (20130101)
B01L 2300/048 (20130101)
B01L 2300/123 (20130101)
B01L 2300/161 (20130101)
B01L 2300/0838 (20130101)
B01L 2400/0406 (20130101)
B01L 2400/0487 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/14 (20130101)
G01N 2001/149 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017453 Ruprecht et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) University of Louisiana at Lafayette (Lafayette, Louisiana)
ASSIGNEE(S)
INVENTOR(S) Ruth Ruprecht (San Antonio, Texas);  Siqi Gong (San Antonio, Texas)
ABSTRACT Described herein are methods of inducing an immune response directed towards preventing or reducing the risk of a human immunodeficiency virus (HIV) infection in a mammalian subject. The subject is administered an effective amount of a composition containing IgM antibodies directed to an epitope of an envelope protein of the HIV virus. Also disclosed here are vaccine compositions comprising IgM antibodies directed to one or more epitopes of one or more human immunodeficiency virus envelope proteins. Also disclosed are recombinant immunoglobulin M compositions containing a Fcγ fragment of an immunoglobulin G.
FILED Monday, May 06, 2019
APPL NO 17/052671
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/1805 (20130101)

Acyclic or Carbocyclic Compounds
C07C 209/68 (20130101) Original (OR) Class
C07C 211/48 (20130101)
C07C 227/32 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 1/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017454 RAJ et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Ganesh RAJ (Plano, Texas);  Jung-Mo AHN (Plano, Texas);  Ratna K. VADLAMUDI (Helotes, Texas)
ABSTRACT The present disclosure compounds of the formulae: wherein the variables are defined herein, as well as pharmaceutical compositions thereof. The present disclosure also provides methods for the use of said compounds and/or pharmaceutical compositions, such as in the treatment of cancer.
FILED Thursday, June 03, 2021
APPL NO 17/337830
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Acyclic or Carbocyclic Compounds
C07C 235/56 (20130101) Original (OR) Class

Heterocyclic Compounds
C07D 215/38 (20130101)
C07D 231/56 (20130101)
C07D 233/88 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017495 CHEN et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (Bethesda, Maryland)
ASSIGNEE(S)
INVENTOR(S) Xiaoyuan CHEN (Bethesda, Maryland);  Gang NIU (Bethesda, Maryland);  Lixin LANG (Bethesda, Maryland);  Rui TIAN (Bethesda, Maryland);  Dale O. KIESEWETTER (Bethesda, Maryland)
ABSTRACT A compound of Formula (I) or a pharmaceutically acceptable ester, amide, solvate, or salt thereof, or a salt of such an ester or amide or a solvate of such an ester amide or salt, is disclosed. Compositions comprising the compound and methods of use are also disclosed. Those dimeric Evans Blue derivatives, denoted as N(tEB)2, reversibly bind two molecules of albumin via the two albumin binding regions of each NtEB in the dimer, resulting in significantly increased binding affinity to albumin and extended circulation half-life in vivo. Further, when the N(tEB)2 is conjugated to a peptide therapeutic, the in situ formation of the complex of N(tEB)2 with two albumin molecules resulted in increased resistance of the peptide therapeutic from proteolysis.
FILED Thursday, January 30, 2020
APPL NO 17/294914
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/545 (20170801)
A61K 47/547 (20170801)
A61K 51/0461 (20130101)
A61K 51/0482 (20130101)
A61K 51/0497 (20130101)

Acyclic or Carbocyclic Compounds
C07C 309/50 (20130101)

Heterocyclic Compounds
C07D 251/50 (20130101)
C07D 403/12 (20130101) Original (OR) Class
C07D 403/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017497 RIDKY et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Todd RIDKY (Bryn Mawr, Pennsylvania);  Christopher NATALE (Philadelphia, Pennsylvania)
ABSTRACT The present invention includes compounds, compositions comprising the same, and methods using the compounds and/or compositions therein, for modulating skin pigmentation in a mammalian subject. In certain embodiments, the compounds of the invention treat or prevent skin disorders or diseases associated with hyperpigmentation in the subject. In other embodiments, the compounds of the invention act as antagonist to the non-canonical sex steroid hormone receptor GPRE1 and do not bind to a canonical nuclear estrogen receptor (ER). In yet other embodiments, the compounds of the invention comprise acts as agonists to the non-canonical sex steroid hormone receptor PAQR7 and do not bind to a canonical nuclear progesterone receptor (PR).
FILED Tuesday, September 21, 2021
APPL NO 17/480948
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 8/49 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 17/00 (20180101)
A61P 17/06 (20180101)
A61P 17/14 (20180101)
A61P 17/16 (20180101)
A61P 17/18 (20180101)

Specific Use of Cosmetics or Similar Toilet Preparations
A61Q 17/04 (20130101)
A61Q 19/02 (20130101)

Heterocyclic Compounds
C07D 221/16 (20130101)
C07D 405/04 (20130101) Original (OR) Class
C07D 491/048 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017507 Glenn et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California);  The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Jeffrey S. Glenn (Palo Alto, California);  Michael A. Gelman (New York, New York);  Brandon Tavshanjian (San Francisco, California);  Kevan Shokat (San Francisco, California);  Ingrid Choong (Los Altos, California);  Mark Smith (San Francisco, California)
ABSTRACT Compounds and methods are provided for the treatment of pathogen infections. In some embodiments, the anti-infective compounds have broad spectrum activity against a variety of infective diseases, where the diseases are caused by pathogens containing a basic amino acid PIP-2 pincer (BAAPP) domain that interacts with phosphatidylinositol 4,5-bisphosphate (PIP-2) to mediate pathogen replication. Also provided are methods of inhibiting a PI4-kinase and methods of inhibiting viral infection. In some embodiments, the compound is a PI4-kinase inhibiting compound that is a 5-aryl-thiazole or a 5-heteroaryl-thiazole. The subject compounds may be formulated or provided to a subject in combination with a second anti-infective agent, e.g. interferon, ribivarin, and the like.
FILED Friday, July 09, 2021
APPL NO 17/371653
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)

Heterocyclic Compounds
C07D 277/42 (20130101)
C07D 277/44 (20130101)
C07D 277/46 (20130101)
C07D 417/04 (20130101)
C07D 417/12 (20130101) Original (OR) Class
C07D 417/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017509 Winkler et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S)
INVENTOR(S) Alyssa Winkler (Ann Arbor, Michigan);  Brian Linhares (Ann Arbor, Michigan);  Dymytrii Listunov (Ann Arbor, Michigan);  Jolanta Grembecka (Ann Arbor, Michigan);  Tomasz Cierpicki (Ann Arbor, Michigan);  EunGi Kim (Ann Arbor, Michigan)
ABSTRACT Provided herein are small molecules that bind to GAS41 and inhibit GAS41 activity, and methods of use thereof for the treatment of cancer.
FILED Wednesday, January 27, 2021
APPL NO 17/159916
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/55 (20170801)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Heterocyclic Compounds
C07D 409/06 (20130101)
C07D 409/14 (20130101)
C07D 417/14 (20130101) Original (OR) Class
C07D 487/10 (20130101)
C07D 495/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017510 GRAY et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) DANA-FARBER CANCER INSTITUTE, INC. (BOSTON, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) NATHANAEL S. GRAY (JAMAICA PLAIN, Massachusetts);  JAEBONG JANG (BOSTON, Massachusetts);  DRIES DE CLERCQ (BOSTON, Massachusetts);  MICHAEL ECK (BOSTON, Massachusetts);  PASI JANNE (NEEDHAM, Massachusetts)
ABSTRACT The present application provides bifunctional compounds of Formula (I): which act as protein degradation inducing moieties for EGFR and/or a mutant thereof. The present application also describes methods for the targeted degradation of EGFR and/or a mutant thereof through the use of the bifunctional compounds that link a ubiquitin ligase-binding moiety to a ligand that is capable of binding to EGFR and/or a mutant thereof which can be utilized in the treatment of disorders modulated by EGFR or a mutant thereof.
FILED Monday, September 27, 2021
APPL NO 17/449027
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/18 (20130101)
A61K 47/545 (20170801)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Heterocyclic Compounds
C07D 417/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017559 Renslo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Adam R. Renslo (Oakland, California);  Erica M.W. Lauterwasser (Wachenheim, Germany);  Shaun D. Fontaine (Walnut Creek, California);  Benjamin B. Spangler (San Francisco, California);  James A. Wells (Burlingame, California)
ABSTRACT Disclosed herein, inter alia, are prodrug compositions and methods of using the same for treatment and detection of disease. Specifically, disclosed herein is a compound of formula (I) having spiro-fused 1,2,4-trioxolane and piperidine rings, namely, 1,2,4-trioxa-8-azaspiro[4.5] decane. Also disclosed is a pharmaceutical composition containing the compound and a pharmaceutically acceptable carrier.
FILED Thursday, April 22, 2021
APPL NO 17/237525
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/357 (20130101)
A61K 31/404 (20130101)
A61K 31/427 (20130101)
A61K 31/435 (20130101)
A61K 31/437 (20130101)
A61K 31/444 (20130101)
A61K 31/496 (20130101)
A61K 31/513 (20130101)
A61K 31/662 (20130101)
A61K 31/4025 (20130101)
A61K 31/4192 (20130101)
A61K 31/4709 (20130101)
A61K 31/4745 (20130101)
A61K 31/4985 (20130101)
A61K 31/7072 (20130101)
A61K 31/7076 (20130101)
A61K 31/7135 (20130101)
A61K 47/64 (20170801)
A61K 47/6803 (20170801)
A61K 51/0459 (20130101)

General Methods of Organic Chemistry; Apparatus Therefor
C07B 2200/05 (20130101)

Heterocyclic Compounds
C07D 323/02 (20130101)
C07D 405/12 (20130101)
C07D 405/14 (20130101)
C07D 407/12 (20130101)
C07D 417/12 (20130101)
C07D 417/14 (20130101)
C07D 471/14 (20130101)
C07D 487/04 (20130101)
C07D 491/107 (20130101)
C07D 491/113 (20130101)
C07D 491/153 (20130101)
C07D 493/04 (20130101)
C07D 493/14 (20130101)
C07D 519/04 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/1804 (20130101)
C07F 9/65517 (20130101)
C07F 9/65586 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 19/06 (20130101)
C07H 19/16 (20130101) Original (OR) Class
C07H 19/167 (20130101)

Peptides
C07K 7/06 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017575 Agbandje-McKenna et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
INVENTOR(S) Mavis Agbandje-McKenna (Gainesville, Florida);  Mario Mietzsch (Gainesville, Florida)
ABSTRACT This disclosure relates to variant AAVrh 10 particles engineered to escape host neutralizing antibodies but retain or improve transduction efficiency, and their use as gene delivery vehicles.
FILED Friday, June 25, 2021
APPL NO 17/359324
CURRENT CPC
Peptides
C07K 14/005 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2015/8518 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017577 Kennedy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Matthew Kennedy (Denver, Colorado);  Chandra Tucker (Denver, Colorado)
ABSTRACT The present invention includes light-controlled and light-independent neurotoxin systems and methods for using such neurotoxin systems for rapidly and locally silencing distinct populations of neurons.
FILED Thursday, November 21, 2019
APPL NO 17/295736
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/33 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/52 (20130101)
C12N 15/62 (20130101)

Enzymes
C12Y 304/24069 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017578 REED et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Infectious Disease Research Institute (Seattle, Washington)
ASSIGNEE(S)
INVENTOR(S) Steven G. REED (Bellevue, Washington);  Rhea N. COLER (Seattle, Washington);  Gregory C. IRETON (Seattle, Washington);  Sylvie BERTHOLET (Gaithersburg, Maryland)
ABSTRACT The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sr) antigens, and polynucleotides encoding such compositions and fusion proteins, The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
FILED Tuesday, July 06, 2021
APPL NO 17/367812
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/04 (20130101)
A61K 2039/55561 (20130101)

Peptides
C07K 14/35 (20130101) Original (OR) Class
C07K 14/285 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/68 (20130101)
G01N 33/5695 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017579 CHEN et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) UNIVERSITY OF WASHINGTON (Seattle, Washington)
ASSIGNEE(S)
INVENTOR(S) Zibo CHEN (Seattle, Washington);  Scott BOYKEN (Seattle, Washington);  Sherry BERMEO (Seattle, Washington);  Robert A. LANGAN (Seattle, Washington);  David BAKER (Seattle, Washington)
ABSTRACT Disclosed herein are designed heterodimer proteins, monomeric polypeptides capable of forming heterodimer proteins, protein scaffolds including such polypeptides, and methods for using the heterodimer proteins and subunit polypeptides for designing logic gates.
FILED Thursday, September 23, 2021
APPL NO 17/482713
CURRENT CPC
Peptides
C07K 14/435 (20130101) Original (OR) Class
C07K 2319/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/53 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017604 Ellebedy et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) Washington University (St. Louis, Missouri)
INVENTOR(S) Ali Ellebedy (St. Louis, Missouri);  Aaron Schmitz (St. Louis, Missouri);  Jackson Turner (St. Louis, Missouri);  Wafaa Al Soussi (St. Louis, Missouri);  Michael Diamond (St. Louis, Missouri);  Daved Fremont (St. Louis, Missouri);  James Brett Case (St. Louis, Missouri);  Haiyan Zhao (St. Louis, Missouri);  Adrianus Boon (St. Louis, Missouri);  Sean Whelan (St. Louis, Missouri);  Andrew McCluskey (Holden, Massachusetts);  Christopher Negron (Worcester, Massachusetts)
ABSTRACT The present invention relates to antibodies or antigen-binding fragments that are useful for treating coronavirus infections (e.g., COVID-19 caused by SARS-CoV-2). The present invention also relates to various pharmaceutical compositions and methods of treating coronavirus using the antibodies or antigen-binding fragments.
FILED Friday, April 16, 2021
APPL NO 17/232796
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/215 (20130101)
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)

Peptides
C07K 16/10 (20130101) Original (OR) Class
C07K 2317/24 (20130101)
C07K 2317/76 (20130101)
C07K 2317/92 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017609 Hansen et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Yale University (New Haven, Connecticut);  The Regents of the University of California (Oakland, California);  The United States Government represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) James E. Hansen (Guilford, Connecticut);  Peter M. Glazer (Guilford, Connecticut);  Richard H. Weisbart (Los Angeles, California);  Robert N. Nishimura (Santa Monica, California);  Grace Chan (Monterey Park, California)
ABSTRACT Antibodies that penetrate cell nuclei and inhibit DNA repair or interfere with DNA metabolism are provided for treatment of cancer (both directly and by sensitizing cancer cells to DNA-damaging treatments) or inhibiting or preventing viral infection, proliferation or metabolism. The method involves treating cells with a composition containing cell-penetrating anti-DNA antibodies or derivatives thereof, alone or in combination with treatment that induces DNA damage such as DNA-damaging chemotherapy or radiation. The impact of the cell-penetrating anti-DNA antibodies or derivatives thereof is potentiated in cancer cells that are deficient in DNA repair, and the cell-penetrating anti-DNA antibodies or derivatives thereof are synthetically lethal to cancer cells with DNA repair deficiencies.
FILED Friday, March 05, 2021
APPL NO 17/193933
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/337 (20130101)
A61K 31/475 (20130101)
A61K 31/513 (20130101)
A61K 31/704 (20130101)
A61K 31/7068 (20130101)
A61K 33/243 (20190101)
A61K 39/39558 (20130101)
A61K 45/06 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/18 (20130101) Original (OR) Class
C07K 16/44 (20130101)
C07K 2317/73 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017610 Aikawa et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Brigham and Women`s Hospital, Inc. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Masanori Aikawa (Chestnut Hill, Massachusetts);  Toshiaki Nakano (Fukuoka, Japan);  Shunsuke Katsuki (Brookline, Massachusetts)
ABSTRACT The present invention is directed to antibodies that interact with DLL4 and inhibit it from binding to NOTCH receptors. The invention also includes nucleic acids encoding the antibodies and methods of using the antibodies in research and in the prevention or treatment of various diseases and conditions.
FILED Thursday, November 14, 2019
APPL NO 17/294147
CURRENT CPC
Peptides
C07K 16/18 (20130101) Original (OR) Class
C07K 2317/24 (20130101)
C07K 2317/92 (20130101)
C07K 2317/565 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/563 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017613 Lukacs et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
ASSIGNEE(S)
INVENTOR(S) Nicholas W. Lukacs (Brighton, Michigan);  Vladislav A. Dolgachev (Ann Arbor, Michigan);  Steven L. Kunkel (Ann Arbor, Michigan);  Cory M. Hogaboam (Ann Arbor, Michigan);  Sem H. Phan (Ann Arbor, Michigan)
ABSTRACT Provided herein are methods, compositions, and uses relating to inhibitors of stem cell factor. For example, provided herein are antibodies targeting stem cell factor and methods for treating fibrotic and tissue remodeling diseases.
FILED Monday, October 04, 2021
APPL NO 17/493411
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/007 (20130101)
A61K 9/08 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/22 (20130101)
C07K 16/24 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017715 Chen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) DOW GLOBAL TECHNOLOGIES LLC (Midland, Michigan);  DOW BRASIL SUDESTE INDUSTRIAL LTDA. (Sao Paulo/Sp, Brazil);  ROHM AND HAAS COMPANY (Collegeville, Pennsylvania);  YALE UNIVERSITY (New Haven, Connecticut)
ASSIGNEE(S)
INVENTOR(S) Sidi Chen (Milford, Connecticut);  Matthew Dong (San Francisco, California)
ABSTRACT The present invention includes compositions and methods for enhancing T cell based immunotherapy. In certain aspects, the invention includes modified T cells and inhibitors of Dhx37 for use in enhancing T cell based immunotherapy and treating cancer.
FILED Friday, June 22, 2018
APPL NO 16/625542
CURRENT CPC
Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 7/048 (20200101) Original (OR) Class
C08J 7/0427 (20200101)
C08J 2323/08 (20130101)
C08J 2323/14 (20130101)
C08J 2475/04 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 7/62 (20180101)
C09D 175/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017863 Kim
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, Florida)
ASSIGNEE(S)
INVENTOR(S) Sungjune Kim (Tampa, Florida)
ABSTRACT Disclosed herein are lymphocytes for use in adoptive cell transfer that have chemically- or genetically-inhibited Sirt2 expression. Also disclosed are methods of inhibiting or ablating Sirt2 expression in a T cell ex vivo. Also disclosed are methods of treating cancer in a subject that involves collecting lymphocytes, such as tumor infiltrating lymphocytes (TILs), from the subject, treating the lymphocytes ex vivo to inhibit Sirt2 expression, and transferring the modified lymphocytes back to the subject.
FILED Thursday, February 06, 2020
APPL NO 17/298257
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)
A61K 39/39558 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/04 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101) Original (OR) Class
C12N 2501/065 (20130101)
C12N 2510/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017865 FRAZÃO et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) THE CHILDREN'S MEDICAL CENTER CORPORATION (Boston, Massachusetts);  UNIVERSITY OF MASSACHUSETTS (Boston, Massachusetts)
ASSIGNEE(S) THE CHILDREN'S MEDICAL CENTER CORPORATION (Boston, Massachusetts);  UNIVERSITY OF MASSACHUSETTS (Boston, Massachusetts)
INVENTOR(S) Josias Brito FRAZÃO (Boston, Massachusetts);  Scot A. WOLFE (Boston, Massachusetts);  Daniel E. BAUER (Boston, Massachusetts);  Shuquan RAO (Boston, Massachusetts);  Peter E. NEWBURGER (Boston, Massachusetts)
ABSTRACT Provided herein are reagents and methods for targeting the ELANE gene for inhibition. Further provided herein is a method for producing a progenitor cell or a population of progenitor cells having decreased ELANE mRNA or protein expression.
FILED Wednesday, November 27, 2019
APPL NO 17/297925
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0642 (20130101) Original (OR) Class
C12N 9/22 (20130101)
C12N 15/907 (20130101)
C12N 15/1137 (20130101)
C12N 2310/20 (20170501)
C12N 2501/22 (20130101)
C12N 2501/26 (20130101)
C12N 2501/125 (20130101)
C12N 2501/2306 (20130101)
C12N 2510/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017873 Thomson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S)
INVENTOR(S) James A. Thomson (Madison, Wisconsin);  William L. Murphy (Waunakee, Wisconsin);  Charles D. Page (Sun Prairie, Wisconsin);  Michael P. Schwartz (Madison, Wisconsin);  Zhonggang Hou (Madison, Wisconsin)
ABSTRACT The present invention relates to three-dimensional (3D) tissue constructs and methods of using such 3D tissue constructs to screen for neurotoxic agents. In particular, provided herein are methods of producing and using complex, highly uniform human tissue models comprising physiologically relevant human cells, where the tissue models have the degree of sample uniformity and reproducibility required for use in quantitative high-throughput screening applications.
FILED Monday, July 12, 2021
APPL NO 17/373523
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0619 (20130101)
C12N 5/0622 (20130101)
C12N 5/0697 (20130101) Original (OR) Class
C12N 2502/28 (20130101)
C12N 2502/1358 (20130101)
C12N 2503/02 (20130101)
C12N 2506/02 (20130101)
C12N 2533/30 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5058 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017876 Schaffer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) David V. Schaffer (Danville, California);  Melissa A. Kotterman (Berkeley, California);  Bum-Yeol Hwang (Moraga, California);  James T. Koerber (San Mateo, California)
ABSTRACT The present disclosure provides infectious recombinant adeno-associated virus (rAAV) virions that comprise a variant capsid protein and a heterologous nucleic acid. The present disclosure further provides the variant adeno-associated virus (AAV) capsid proteins (and/or a nucleic acid encoding the variant AAV capsid proteins), which confer to an infectious rAAV virion an increased resistance to human AAV neutralizing antibodies. The present disclosure further provides host cells comprising an infectious rAAV virion and/or a nucleic acid encoding a subject variant AAV capsid protein. The present disclosure further provides methods of delivering a heterologous nucleic acid to a target cell where the target cell is contacted with a subject infectious rAAV virion. The present disclosure further provides methods of delivering a gene product to an individual, the methods generally involving administering an effective amount of a subject rAAV virion to an individual in need thereof.
FILED Tuesday, September 07, 2021
APPL NO 17/468290
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/76 (20130101)
A61K 35/761 (20130101)
A61K 48/005 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101) Original (OR) Class
C12N 15/86 (20130101)
C12N 15/1058 (20130101)
C12N 2750/14122 (20130101)
C12N 2750/14143 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017882 Marson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Alexander Marson (Oakland, California);  Theodore Lee Roth (Oakland, California);  Daniel Goodman (Oakland, California);  David-Huy Nhu Nguyen (Oakland, California);  Francis C. Szoka (Oakland, California)
ABSTRACT The disclosure provides compositions and methods for modifying a target nucleic acid. In some embodiments, a composition can include a targetable nuclease, a DNA-binding protein, and a donor template comprising a homology directed repair (HDR) template and one or more DNA-binding protein target sequences. In some embodiments, a composition can include a Cas protein, one or more single guide RNAs (sgRNAs), and an anionic polymer.
FILED Thursday, December 12, 2019
APPL NO 17/312191
CURRENT CPC
Peptides
C07K 2319/09 (20130101)
C07K 2319/80 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101) Original (OR) Class
C12N 15/11 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)
C12N 2800/80 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017883 Joung et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) J. Keith Joung (Winchester, Massachusetts);  Benjamin Kleinstiver (Boston, Massachusetts)
ABSTRACT Engineered CRISPR from Prevotella and Francisella 1 (Cpf1) nucleases with altered and improved target specificity and their use in genomic engineering, epigenomic engineering, genome targeting, genome editing, and in vitro diagnostics.
FILED Tuesday, October 12, 2021
APPL NO 17/450588
CURRENT CPC
Peptides
C07K 14/39 (20130101)
C07K 2319/00 (20130101)
C07K 2319/80 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101) Original (OR) Class
C12N 9/0071 (20130101)
C12N 15/11 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)

Enzymes
C12Y 114/11 (20130101)
C12Y 301/21004 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017905 KEMP et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Fred Huchinson Cancer Research Center (Seattle, Washington)
ASSIGNEE(S)
INVENTOR(S) Christopher KEMP (Seattle, Washington);  Carla GRANDORI (Seattle, Washington);  Eduardo MENDEZ (Seattle, Washington);  Russell MOSER (Seattle, Washington);  Chang XU (Mercer Island, Washington)
ABSTRACT The present invention provides methods for treating cancers having a mutation in one or more tumor suppressor genes, comprising providing to a subject in need thereof an inhibitor of a kinase, as well as related methods and compositions.
FILED Monday, January 25, 2021
APPL NO 17/157565
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/407 (20130101)
A61K 31/426 (20130101)
A61K 31/506 (20130101)
A61K 31/519 (20130101)
A61K 31/713 (20130101)
A61K 31/4535 (20130101)
A61K 31/5377 (20130101)
A61K 33/24 (20130101)
A61K 33/243 (20190101)
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1137 (20130101) Original (OR) Class
C12N 2310/14 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5011 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017938 MIKKELSEN et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE BROAD INSTITUTE, INC. (CAMBRIDGE, Massachusetts);  PRESIDENT AND FELLOWS OF HARVARD COLLEGE (CAMBRIDGE, Massachusetts);  THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (BOSTON, Massachusetts)
ASSIGNEE(S) THE BROAD INSTITUTE, INC. (CAMBRIDGE, Massachusetts);  PRESIDENT AND FELLOWS OF HARVARD COLLEGE (CAMBRIDGE, Massachusetts);  THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (BOSTON, Massachusetts)
INVENTOR(S) TARJEI MIKKELSEN (CAMBRIDGE, Massachusetts);  BENJAMIN LEVINE EBERT (BOSTON, Massachusetts);  QUINLAN SIEVERS (BOSTON, Massachusetts)
ABSTRACT In one aspect, the invention features a method for identifying a drug-modulated polypeptide substrate of cereblon (CRBN). In another aspect, the invention features a method of identifying a polypeptide target of a modulator of CRBN. In yet another aspect, the invention provides methods of monitoring or characterizing the sensitivity of a subject to a modulator of CRBN.
FILED Thursday, October 07, 2021
APPL NO 17/496578
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/025 (20130101) Original (OR) Class
C12Q 1/68 (20130101)
C12Q 1/6883 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/156 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/68 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017945 DEAN et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Children's Hospital and Research Center at Oakland (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Deborah Anne DEAN (San Anselmo, California);  Noor ALNABELSEYA (Oakland, California)
ABSTRACT Disclosed herein are novel methods and compositions for rapidly extracting and amplifying nucleic acids from a sample where the sample is combined with an extraction reagent comprising a reducing agent to form a mixture and incubating said mixture at ambient temperature for a period of time not exceeding 30 minutes to generate a nucleic acid extract. In certain embodiments of the method, the nucleic acid extract is subjected to a nucleic acid amplification reaction. In certain aspects, oligonucleotide primers specific for nucleic acids of Chlamydia species and/or Neisseria species are added prior to initiating the amplification reaction.
FILED Tuesday, July 13, 2021
APPL NO 17/374255
CURRENT CPC
Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 1/06 (20130101)
C07H 21/00 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/689 (20130101)
C12Q 1/6806 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017946 Okereke et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S)
INVENTOR(S) Ikenna Okereke (Galveston, Texas);  Richard Pyles (Galveston, Texas);  Aaron Miller (Galveston, Texas);  Catherine Hamilton (Galveston, Texas)
ABSTRACT The present invention includes a method of detecting and treating a patient suspected of having Barrett's esophagus comprising: obtaining a biological sample from an esophagus of the patient; determining a microbiome in the biological sample by detecting the presence of bacteria by plasmid dilution verification or quantitative polymerase chain reaction (qPCR); wherein if the patient has a microbiome indicative of an increased risk of esophageal cancer threating the patient with at least one of: removing at least part of the esophagus, esophagectomy probiotic therapy, or chemically targeting elimination of bacteria indicative of an increased risk of esophageal cancer.
FILED Wednesday, July 14, 2021
APPL NO 17/375966
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101) Original (OR) Class
C12Q 2600/112 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017961 SALK et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute on Aging (NIA)
APPLICANT(S) UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (SEATTLE, Washington)
ASSIGNEE(S)
INVENTOR(S) Jesse SALK (Seattle, Washington);  Lawrence A. LOEB (Bellevue, Washington);  Michael SCHMITT (Seattle, Washington)
ABSTRACT Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand. This method uniquely capitalizes on the redundant information stored in double-stranded DNA, thus overcoming technical limitations of prior methods utilizing data from only one of the two strands.
FILED Monday, September 27, 2021
APPL NO 17/448985
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101)
C12Q 1/6869 (20130101)
C12Q 1/6876 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017965 Aliferis et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Cancer Institute (NCI)
APPLICANT(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Konstantinos Aliferis (Minneapolis, Minnesota);  Boris Jan Nils Winterhoff (Minneapolis, Minnesota);  Sisi Ma (Minneapolis, Minnesota);  Jinhua Wang (Edina, Minnesota)
ABSTRACT This disclosure describes methods of predicting the response of a patient with ovarian cancer to platinum-based chemotherapy and/or treatment with bevacizumab using clinical and molecular tumor characteristics in patients, methods of treating patients with ovarian cancer, and kits for performing all or part of the methods described herein. This disclosure also describes methods that include determining a prediction of an outcome for a patient having ovarian cancer based on one or more signatures and patient test data comprising clinical data, gene expression data, or both.
FILED Thursday, October 31, 2019
APPL NO 17/290172
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/118 (20130101)
C12Q 2600/158 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 10/40 (20180101)
G16H 20/10 (20180101)
G16H 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017969 Curiel et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (Tucson, Arizona);  George Mason University (Manassas, Virginia)
ASSIGNEE(S)
INVENTOR(S) Clara N. Curiel (Tucson, Arizona);  Amanda Fern Baker (Tucson, Arizona);  Sally E. Dickinson (Tucson, Arizona);  Emanuel F. Petricoin, III (Manassas, Virginia)
ABSTRACT The present invention relates to a method of using family and/or regulatory members of the PD-1/PD-L1 pathway as predictive markers for risk of skin cancer development and as targets for therapeutic prevention of pre-malignant (or pre-cancerous) skin lesions and non-melanoma skin cancer (NMSC). This invention will allow for quantitative measurements of UV-induced expression of PD-1/PD-Li signaling pathway family members (e.g., PD-1, PD-L1, PD-L2) and/or PD-1/PD-L1 regulatory factors including AP-1 and NFκB family members in skin tissue of individuals to determine an individual's 1) risk for skin cancer development and 2) appropriate prophylactic treatment strategy to prevent skin cancer development. This information will facilitate identification of those patients at risk for pre-malignant (or pre-cancerous) skin lesions or subsequent NMSC lesions who would benefit from a PD-1/PD-L1 pathway suppressing therapy to prevent skin cancer development.
FILED Friday, December 06, 2019
APPL NO 17/311538
CURRENT CPC
Peptides
C07K 14/705 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/158 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017978 Koralnik et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Igor J. Koralnik (Chicago, Illinois);  Barbara A. Hanson (Chicago, Illinois);  Xin Dang (Burr Ridge, Illinois)
ABSTRACT The invention relates to methods, systems, and components thereof for detecting and discovering viruses in a clinical sample. In particular, the invention relates to methods, systems, and components thereof for detecting and discovering a plurality of viruses in a clinical sample.
FILED Wednesday, July 14, 2021
APPL NO 17/305796
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/701 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018759 PHAL et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Yamuna PHAL (Champaign, Illinois);  Kevin Lee YEH (Corvallis, Oregon);  Rohit BHARGAVA (Urbana, Illinois)
ABSTRACT Methods and apparatus for obtaining a vibrational circular dichroism (VCD) image using a discrete frequency infrared (DFIR) microscope are disclosed. The method includes generating a pulsed laser beam comprising a spectral frequency, which may be tunable; modulating the laser beam to generate circularly polarized light; illuminating a sample and collecting, and detecting an optical signal transmitted or transflected from the location of the sample. The detected signal is demodulated at, for example, both the pulse frequency and the sum or difference of the pulse frequency and the modulating frequency to obtain an intensity value that correspond to the absorbance, and a polarization-dependent value that corresponds to the VCD. Other configurations of the apparatus may be employed to measure VCB and VLD.
FILED Thursday, July 15, 2021
APPL NO 17/377096
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/108 (20130101)
G01J 3/433 (20130101)
G01J 3/447 (20130101)
G01J 3/2823 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/19 (20130101) Original (OR) Class
G01N 21/23 (20130101)
G01N 21/39 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018779 YAO et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) CLEMSON UNIVERSITY (Clemson, South Carolina)
ASSIGNEE(S)
INVENTOR(S) HAI YAO (CLEMSON, South Carolina);  TONG YE (CLEMSON, South Carolina);  PENG CHEN (CLEMSON, South Carolina);  XUN CHEN (CLEMSON, South Carolina)
ABSTRACT Herein are described data acquisition systems and methods applying such systems to determine three-dimensional (3D) diffusion tensors, and simultaneously, to perform 3D structure imaging. Example data acquisition systems can include computing systems in communication with modified light sheet microscopes that are configured for high-speed volumetric imaging to record 3D diffusion processes and high-resolution 3D structural imaging.
FILED Friday, July 16, 2021
APPL NO 17/378093
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6458 (20130101)
G01N 21/6486 (20130101) Original (OR) Class

Optical Elements, Systems, or Apparatus
G02B 21/008 (20130101)
G02B 21/0032 (20130101)
G02B 21/0076 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018808 Tao et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Shaopeng Wang (Chandler, Arizona);  Runli Liang (Mesa, Arizona)
ASSIGNEE(S)
INVENTOR(S) Nongjian Tao (Fountain Hills, Arizona);  Shaopeng Wang (Chandler, Arizona);  Runli Liang (Mesa, Arizona)
ABSTRACT A system for detecting target molecules includes a sample well defining a sensing region and two electrode regions, a sensor positioned in the sensing region and sensitized to the target molecules, an electrode positioned in each electrode region and configured to expose the sensor to a frequency-modulated electric field, and a detector configured to detect both an amplitude of oscillation of the sensor at a frequency of the modulated electric field and a direction of a displacement of the sensor. The sensing region defines a channel between the electrodes, and a ratio of a current density at a center of the sensing region to a current density at one of the electrodes is at least 2. The system allows detection of target molecules in a normal ionic strength buffer (e.g., having an ionic strength in a range of about 10 mM to about 1 M).
FILED Wednesday, July 14, 2021
APPL NO 17/375231
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6428 (20130101)
G01N 21/6458 (20130101)
G01N 27/44791 (20130101) Original (OR) Class
G01N 2021/6439 (20130101)
G01N 2201/088 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018920 Stautner
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) General Electric Company (Schenectady, New York)
ASSIGNEE(S)
INVENTOR(S) Ernst Wolfgang Stautner (Niskayuna, New York)
ABSTRACT The present disclosure relates to a cooling system that includes a superconducting unit and a reservoir configured to store liquid coolant to cool the superconducting unit. The cooling system also includes an auxiliary storage system that includes one or more storage tanks fluidly coupled to the reservoir. The auxiliary storage system is configured to provide additional coolant to the reservoir as well as receive and store coolant from the reservoir.
FILED Tuesday, July 14, 2020
APPL NO 16/928858
CURRENT CPC
Vessels for Containing or Storing Compressed, Liquefied or Solidified Gases; Fixed-capacity Gas-holders; Filling Vessels With, or Discharging From Vessels, Compressed, Liquefied, or Solidified Gases
F17C 7/04 (20130101)
F17C 2221/017 (20130101)
F17C 2227/0337 (20130101)
F17C 2270/0536 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/3856 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018922 Shim et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Emory University (Atlanta, Georgia);  University of Miami (Miami, Florida)
ASSIGNEE(S)
INVENTOR(S) Hyunsuk Shim (Atlanta, Georgia);  Lee Cooper (Atlanta, Georgia);  Saumya Gurbani (Atlanta, Georgia);  Andrew Maudsley (Miami, Florida);  Sulaiman Sheriff (Miami, Florida)
ABSTRACT Systems and methods provide a parallelized deep learning approach to spectral fitting for magnetic resonance spectroscopy data enabling accurate and rapid spectral fitting and determination of metabolite measurements using a conventional computer. The method may include processing multi-spectra magnetic resonance (MR) spectroscopy data of a region of interest through a series of neural networks. The method may include determining baseline components of each spectrum using a first neural network of the series, generating baseline-corrected components for each spectrum using the baseline components; and determining one or more peak components of each spectrum using a second neural network of the series and the baseline-corrected components. The method may further include determining one or more metabolite measurements of the one or more metabolites in the region of interest using the one or more peak components.
FILED Wednesday, November 20, 2019
APPL NO 17/295528
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/485 (20130101) Original (OR) Class
G01R 33/4625 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/084 (20130101)
G06N 3/0454 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019861 DURR et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Nicholas J. DURR (Baltimore, Maryland);  Taylor L. BOBROW (Chesapeake, Virginia);  Faisal MAHMOOD (Baltimore, Maryland)
ABSTRACT A device may receive a coherent energy illuminated image, of a particular object, that includes laser speckle. The device may process, using a laser speckle reduction model, the coherent energy illuminated image to generate a laser speckle-reduced image. The device may provide the laser speckle-reduced image as output to permit diagnostics based on the laser speckle-reduced image.
FILED Tuesday, October 22, 2019
APPL NO 17/309100
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/6267 (20130101) Original (OR) Class

Computer Systems Based on Specific Computational Models
G06N 3/088 (20130101)
G06N 3/0454 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 30/20 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 20220015339 Maselko et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Maciej Bozyslaw Maselko (Sydney, Australia);  Przemyslaw Bajer (New Brighton, Minnesota);  Siba Ranjan Das (Falcon Heights, Minnesota);  James Parker (Minneapolis, Minnesota);  Michael Joseph Smanski (Falcon Heights, Minnesota);  Ambuj Upadhyay (Falcon Heights, Minnesota)
ABSTRACT A system for controlling population of a biological species includes a population of genetically-modified individuals of the biological species, where both males and females in the genetically-modified population carry two mutations. The first mutation is a repressible genetic mutation that results in death of a juvenile individual of the first sex when the juvenile individual of the first sex comprises the repressible lethal mutation and is reared in the absence of a repressor or causes an individual to be sterile when reared in the absence of a repressor. The second mutation is an underdominant genetic mutation.
FILED Tuesday, November 05, 2019
APPL NO 17/288628
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0275 (20130101) Original (OR) Class
A01K 67/0333 (20130101)
A01K 2217/072 (20130101)
A01K 2227/40 (20130101)
A01K 2227/706 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016153 PAINTER et al.
FUNDED BY
Department of Defense (DOD)
Defense Threat Reduction Agency (DTRA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Centers of Excellence for Influenza Research and Surveillance (CEIRS)
APPLICANT(S) EMORY UNIVERSITY (Atlanta, Georgia)
ASSIGNEE(S)
INVENTOR(S) George R. PAINTER (Atlanta, Georgia);  Gregory R. Bluemling (Decatur, Georgia);  Michael G. Natchus (Alpharetta, Georgia);  David Guthrie (Avondale Estates, Georgia)
ABSTRACT This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.
FILED Thursday, September 02, 2021
APPL NO 17/465344
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7068 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/12 (20180101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 19/067 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016185 Hsiao et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S)
INVENTOR(S) Elaine Hsiao (Rowland Heights, California);  Sara McBride (Pasadena, California);  Sarkis K. Mazmanian (Porter Ranch, California);  Paul H. Patterson (Altadena, California)
ABSTRACT Some embodiments include bacterial species for use in treatment of one or more autism spectrum disorder (ASD), and/or schizophrenia symptoms in a subject in need thereof. The bacterial species can include Bacteroides (e.g., B. fragilis, B. thetaiotaomicron, and/or B. vulgatus), and/or Enterococcus (e.g., E. faecalis, E. faecium, E. hirae, E. avium, E. durans, E. gallinarum, or E. casseliflavus). Upon treatment, one or more ASD-related behaviors can be improved in the subject.
FILED Thursday, June 10, 2021
APPL NO 17/303946
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/74 (20130101)
A61K 35/744 (20130101) Original (OR) Class
A61K 2035/115 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016622 Hunt et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) SiO2 Medical Products, Inc. (Auburn, Alabama);  Sanaria Inc. (Rockville, New York)
ASSIGNEE(S)
INVENTOR(S) Benjamin Hunt (Auburn, Alabama);  Chase Bryan Jackson (Auburn, Alabama);  Eric R. James (Rockville, New York)
ABSTRACT Disclosed are container and cap assemblies for cryogenic storage of materials at temperatures below negative 150° C. The container and cap assemblies disclosed maintain container closure integrity and fluid-tightness at ambient and cryogenic temperatures, optionally to preserve biologically active substances stored therein.
FILED Tuesday, December 17, 2019
APPL NO 17/309723
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/50825 (20130101) Original (OR) Class
B01L 2300/042 (20130101)
B01L 2300/044 (20130101)
B01L 2300/0858 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016760 KARTALOV et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Secretary of the Navy (SECNAV)
APPLICANT(S) THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (Arlington, Virginia)
ASSIGNEE(S)
INVENTOR(S) Emil Paskalev KARTALOV (Pacific Grove, California);  Michelangelo COLTELLI (Marina, California);  Jeffrey CATTERLIN (Salinas, California)
ABSTRACT A microcapacitor array for providing artificial muscles is described. The microcapacitor array includes a dielectric body with electrode chambers, positive electrodes in positive electrode chambers, the positive electrodes being connected by a first set of channels in the dielectric frame; negative electrodes in negative electrode chambers, the negative electrodes being connected by a second set of channels in the dielectric frame. The first and second set of channels are arranged so that application of a voltage differential between the positive electrodes and the negative electrodes generates an attractive force between each set of adjacent positive and negative electrodes.
FILED Wednesday, July 14, 2021
APPL NO 17/376068
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 9/12 (20130101)
B25J 9/1075 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017017 Mueller et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Secretary of the Air Force (SECAF)
APPLICANT(S) Government of the United States, as represented by the Secretary of the Air Force (Wright-Patterson AFB, Ohio)
ASSIGNEE(S)
INVENTOR(S) Michael Mueller (Yorktown, Virginia);  ALEXANDER ORSI (DAYTON, Ohio);  JOHN BALES (BEAVERCREEK, Ohio)
ABSTRACT A firearm rack assembly for securing at least one firearm that is removably attachable to a vehicle. The rack including a rifle attachment assembly, a pistol attachment assembly, an assembly post assembly wherein the rifle attachment assembly and pistol attachment assembly are removably joined to the assembly post and the assembly post is removably attachable to the vehicle.
FILED Sunday, May 23, 2021
APPL NO 17/327735
CURRENT CPC
Vehicles, Vehicle Fittings, or Vehicle Parts, Not Otherwise Provided for
B60R 7/14 (20130101) Original (OR) Class

Functional Features or Details Common to Both Smallarms and Ordnance, e.g Cannons; Mountings for Smallarms or Ordnance
F41A 23/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017063 Shukla et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Oshkosh Defense, LLC (Oshkosh, Wisconsin)
ASSIGNEE(S) Oshkosh Defense, LLC (Oshkosh, Wisconsin)
INVENTOR(S) Deepak Shukla (Oshkosh, Wisconsin);  Rongjun Zhang (Neenah, Wisconsin);  Nader Nasr (Neenah, Wisconsin)
ABSTRACT A drive train for a vehicle includes a first electromagnetic device, a second electromagnetic device electrically coupled to the first electromagnetic device by an electrical power transmission system, and an engine coupled to the first electromagnetic device and configured to drive the first electromagnetic device to provide electrical energy. In all modes of operation where the engine drives the first electromagnetic device to provide the electrical energy, the first electromagnetic device operates without providing the electrical energy to an energy storage device.
FILED Friday, October 01, 2021
APPL NO 17/492081
CURRENT CPC
Arrangement or Mounting of Propulsion Units or of Transmissions in Vehicles; Arrangement or Mounting of Plural Diverse Prime-movers in Vehicles; Auxiliary Drives for Vehicles; Instrumentation or Dashboards for Vehicles; Arrangements in Connection With Cooling, Air Intake, Gas Exhaust or Fuel Supply of Propulsion Units in Vehicles
B60K 6/26 (20130101)
B60K 6/34 (20130101)
B60K 6/52 (20130101)
B60K 6/365 (20130101)
B60K 6/387 (20130101)
B60K 6/445 (20130101)
B60K 6/543 (20130101)

Propulsion of Electrically-propelled Vehicles; Supplying Electric Power for Auxiliary Equipment of Electrically-propelled Vehicles; Electrodynamic Brake Systems for Vehicles in General; Magnetic Suspension or Levitation for Vehicles; Monitoring Operating Variables of Electrically-propelled Vehicles; Electric Safety Devices for Electrically-propelled Vehicles
B60L 50/11 (20190201)

Conjoint Control of Vehicle Sub-units of Different Type or Different Function; Control Systems Specially Adapted for Hybrid Vehicles; Road Vehicle Drive Control Systems for Purposes Not Related to the Control of a Particular Sub-unit
B60W 10/02 (20130101)
B60W 10/06 (20130101)
B60W 10/08 (20130101)
B60W 20/10 (20130101) Original (OR) Class
B60W 2510/06 (20130101)
B60W 2510/08 (20130101)
B60W 2510/081 (20130101)
B60W 2510/0604 (20130101)
B60W 2510/0638 (20130101)
B60W 2520/10 (20130101)
B60W 2710/06 (20130101)
B60W 2710/08 (20130101)
B60W 2710/021 (20130101)
B60W 2710/083 (20130101)
B60W 2710/0644 (20130101)
B60W 2710/0677 (20130101)

Indexing Scheme Relating to Aspects Cross-cutting Vehicle Technology
B60Y 2200/92 (20130101)
B60Y 2300/42 (20130101)
B60Y 2300/43 (20130101)
B60Y 2300/60 (20130101)
B60Y 2300/72 (20130101)
B60Y 2400/72 (20130101)
B60Y 2400/73 (20130101)

Gearing
F16H 1/28 (20130101)
F16H 3/72 (20130101)
F16H 3/727 (20130101)
F16H 3/728 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 10/62 (20130101)
Y02T 10/92 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 903/91 (20130101)
Y10S 903/93 (20130101)
Y10S 903/906 (20130101)
Y10S 903/914 (20130101)
Y10S 903/916 (20130101)
Y10S 903/918 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017213 Parsons
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) LOCKHEED MARTIN CORPORATION (Bethesda, Maryland)
ASSIGNEE(S)
INVENTOR(S) Eric S. Parsons (Middlebury, Connecticut)
ABSTRACT A structural member for use in a rotor system which rotates about a rotational axis includes a pin which extends substantially perpendicular to the rotational axis, a filler component positioned adjacent the pin, and a plurality of layers of composite material having fibers oriented lengthwise along a central axis which is perpendicular to the rotational axis. The plurality of fibers in the layers of composite material is wrapped about the pin and the filler component such that the fibers extend along the central axis and the plurality of layers form an opening filled by the filler component and which decreases as a function of distance from the pin along the central axis.
FILED Tuesday, July 14, 2020
APPL NO 16/928605
CURRENT CPC
Aeroplanes; Helicopters
B64C 27/33 (20130101) Original (OR) Class
B64C 27/48 (20130101)
B64C 27/82 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017214 Orbon et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
United States Army (USA)
APPLICANT(S) LOCKHEED MARTIN CORPORATION (Bethesda, Maryland)
ASSIGNEE(S)
INVENTOR(S) James Breen Orbon (New Haven, Connecticut);  James McCollough (Fort Worth, Texas);  Evan S. Tobin (Newtown, Connecticut);  Xiaole Xie (Westport, Connecticut);  Jonathan Frydman (New Haven, Connecticut)
ABSTRACT A propeller system for a tail section of an aircraft includes a propeller hub located at the tail section of the aircraft, a plurality of propeller blades mounted to and extending outwardly from the propeller hub, a propeller shaft coupled to the propeller hub and operable to rotate the propeller hub about an axis of rotation, and a propeller gearbox connected to the propeller shaft. The propeller gearbox is fluidly cooled by an airflow within the tail section. A spinner assembly surrounds the propeller hub. The spinner assembly includes at least one outlet opening formed therein downstream from the propeller hub relative to the airflow. The spinner assembly is rotatable to draw the airflow into at least one cooling flow inlet formed in the tail section and across the propeller gearbox to cool the propeller gearbox and out the at least one outlet opening.
FILED Monday, July 20, 2020
APPL NO 16/933019
CURRENT CPC
Aeroplanes; Helicopters
B64C 27/12 (20130101)
B64C 27/46 (20130101) Original (OR) Class
B64C 2027/8272 (20130101)

Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 13/006 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017215 Dunn et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) LOCKHEED MARTIN CORPORATION (Bethesda, Maryland)
ASSIGNEE(S)
INVENTOR(S) Eric Dunn (Trumbull, Connecticut);  Keith M. Schenone (Fairfield, Connecticut);  Sven R. Lofstrom (Irving, Texas)
ABSTRACT According to an aspect, a method of assembling a mandrel includes assembling a plurality of members via interlocking features arranged at opposing edges of each member of the plurality of members to form a compartment, the assembled members having a collective outer surface that conforms to an inner surface of the spar. A support member is inserted into the compartment formed radially inward from the assembled members, the support member making contact with a portion of each member of the plurality of members.
FILED Tuesday, July 14, 2020
APPL NO 16/928453
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 80/00 (20141201)

Aeroplanes; Helicopters
B64C 27/06 (20130101)
B64C 27/473 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017216 Schmaling et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
United States Army (USA)
APPLICANT(S) LOCKHEED MARTIN CORPORATION (Bethesda, Maryland)
ASSIGNEE(S)
INVENTOR(S) David N. Schmaling (Southbury, Connecticut);  James Breen Orbon (New Haven, Connecticut);  Pedro L. Cabrera (West Haven, Connecticut);  David H. Hunter (Cheshire, Connecticut);  John D. Carroll (Fort Worth, Texas)
ABSTRACT A rotor blade assembly of an aircraft having a rotor hub including a structural member having an inboard end and an outboard end, the structural member being connectable with the rotor hub. A spar surrounds the structural member and extends at least partially along a rotor blade axis. A pitch bearing assembly supports the spar relative to the structural member. The pitch bearing assembly includes an inboard pitch bearing mounted to the inboard end of the structural member and an outboard pitch bearing mounted to the outboard end of the structural member. The rotor blade assembly additionally includes a centrifugal assembly including a centrifugal bearing disposed between the inboard pitch bearing and the outboard pitch bearing relative to the rotor blade axis.
FILED Wednesday, July 15, 2020
APPL NO 16/929889
CURRENT CPC
Aeroplanes; Helicopters
B64C 27/10 (20130101)
B64C 27/473 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017217 Cox
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
United States Army (USA)
APPLICANT(S) LOCKHEED MARTIN CORPORATION (Bethesda, Maryland)
ASSIGNEE(S)
INVENTOR(S) John C. Cox (Jupiter, Florida)
ABSTRACT A swashplate assembly of a rotary wing aircraft includes a first component, a second component arranged concentrically with the first component, and a bearing disposed between the first component and the second component. The bearing includes a spherical bearing and at least one bearing roller element and is operable to transmit torque between the first component and the second component.
FILED Tuesday, July 14, 2020
APPL NO 16/928626
CURRENT CPC
Aeroplanes; Helicopters
B64C 27/605 (20130101) Original (OR) Class

Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/02 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/90 (20130101)
F05D 2240/50 (20130101)
F05D 2240/60 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017230 Speller
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Textron Innovations Inc. (Providence, Rhode Island)
ASSIGNEE(S) Textron Innovations Inc. (, None)
INVENTOR(S) Charles Hubert Speller (Flower Mound, Texas)
ABSTRACT A clutch that has a synchronizer for matching a rotational velocity of a drive input with a rotational velocity of a driven output prior to engagement of a locking mechanism.
FILED Tuesday, May 18, 2021
APPL NO 17/323547
CURRENT CPC
Aeroplanes; Helicopters
B64C 11/28 (20130101)
B64C 27/12 (20130101)
B64C 27/30 (20130101)
B64C 29/0033 (20130101)

Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 35/00 (20130101) Original (OR) Class

Couplings for Transmitting Rotation; Clutches; Brakes
F16D 23/04 (20130101)
F16D 23/06 (20130101)
F16D 25/061 (20130101)
F16D 25/0632 (20130101)
F16D 2023/0693 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017238 Mehra et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) NOVI LLC (Arlington, Virginia)
ASSIGNEE(S) NOVI LLC (Arlington, Virginia)
INVENTOR(S) Amit Mehra (Arlington, Virginia);  Scott Steffan (Hamburg, New York);  Evan Sandler (Fairfax, Virginia)
ABSTRACT A process for rapid re-configuration and customization of small satellites using additively manufactured chassis customized to create a more conformal and integrated bus design adapted to a particular payload. The additional components or subsystems of the bus required are are integrated either on the sidewalls of the additively manufactured chassis, or as the sidewalls of such chassis, while the payload is also secured or integrated via custom features that are part of the additively manufactured chassis. Chassis can be rapidly reconfigured in the design stage to adapt to a preferred vendor's application, components and subsystems, or payload specifications, an engineering change to the bus and/or payload, responsive to test data, or the like, thereafter additively manufacturing a new chassis and rapidly producing the entire small satellite.
FILED Sunday, July 11, 2021
APPL NO 17/372477
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)

Cosmonautics; Vehicles or Equipment Therefor
B64G 1/10 (20130101) Original (OR) Class
B64G 1/22 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 12/40 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017341 Henderson
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
United States Marine Corps (USMC)
APPLICANT(S) Integrated Solution for Systems, Inc. (Huntsville, Alabama)
ASSIGNEE(S) Integrated Solutions for Systems, Inc. (Huntsville, Alabama)
INVENTOR(S) Robert D. Henderson (Huntsville, Alabama)
ABSTRACT The present disclosure is an autonomous robotic cargo system for moving and accurately positioning cargo inside an aircraft or at any other designated location in an austere environment. The system has a chassis coupled to one or more tracks for moving the chassis from a first location to a second location. The chassis is also coupled to one or more forks for loading cargo and unloading the cargo. In addition, the chassis has a laser scanner positioned on the chassis to capture data indicative of the chassis' environment. The system further has a control processor that pre-generates a preliminary pathway for the chassis to travel from the first location to the second location based upon laser scanner data received from the laser scanner. The control processor also controls the one or more forks to pick up cargo and controls the one or more tracks to move the cargo from the first location to the second location.
FILED Wednesday, July 15, 2020
APPL NO 16/930073
CURRENT CPC
Hoisting, Lifting, Hauling or Pushing, Not Otherwise Provided For, e.g Devices Which Apply a Lifting or Pushing Force Directly to the Surface of a Load
B66F 9/063 (20130101) Original (OR) Class
B66F 9/0755 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 1/024 (20130101)
G05D 1/027 (20130101)
G05D 1/0236 (20130101)
G05D 1/0242 (20130101)
G05D 2201/0216 (20130101)

Image Data Processing or Generation, in General
G06T 7/579 (20170101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017534 Lazo et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
ASSIGNEE(S)
INVENTOR(S) John S. Lazo (Charlottesville, Virginia);  Elizabeth Sharlow (Butler, Pennsylvania);  Peter Wipf (Pittsburgh, Pennsylvania);  Nikhil Tasker (Trumbull, Connecticut);  Ettore Rastelli (Pittsburgh, Pennsylvania)
ABSTRACT The disclosure provides compounds that inhibit protein tyrosine phosphatase, such as protein tyrosine phosphatase 4 A3 (PTP4A3). The disclosure also provides pharmaceutical compositions, uses, and methods of using the compounds, such as in the treatment of cancers.
FILED Tuesday, November 12, 2019
APPL NO 17/309259
CURRENT CPC
Heterocyclic Compounds
C07D 495/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017602 LAWRENCE et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
United States Army (USA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Silk Technologies, Ltd. (Plymouth, Minnesota)
ASSIGNEE(S) Silk Technologies, Ltd. (Plymouth, Minnesota)
INVENTOR(S) Brian D. LAWRENCE (Plymouth, Minnesota);  David W. INFANGER (Plymouth, Minnesota);  Yue BAI (Plymouth, Minnesota);  Nicholas PAULSON (Plymouth, Minnesota)
ABSTRACT A biotherapeutic ophthalmic solution that may include a silk-derived protein as an active ingredient. The specific formulation of an ophthalmic composition is critical to meeting user requirements, to the delivery of dosage forms, and to maintaining product stability. The formulations described herein are ophthalmic solutions that are comfortable to the user while product stability is maintained, even after long-term storage. Numerous excipients, manufacturing processes, and container closures were evaluated for their ability to stabilize silk-derived protein under ambient and accelerated conditions. Analyses showed that only a very small subset of vehicle formulations were able to meet the high physiochemical property standards required for stabilizing protein-containing therapeutic ophthalmic solution formulations.
FILED Thursday, July 15, 2021
APPL NO 17/377159
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0048 (20130101)
A61K 47/183 (20130101)

Peptides
C07K 14/78 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017604 Ellebedy et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) Washington University (St. Louis, Missouri)
INVENTOR(S) Ali Ellebedy (St. Louis, Missouri);  Aaron Schmitz (St. Louis, Missouri);  Jackson Turner (St. Louis, Missouri);  Wafaa Al Soussi (St. Louis, Missouri);  Michael Diamond (St. Louis, Missouri);  Daved Fremont (St. Louis, Missouri);  James Brett Case (St. Louis, Missouri);  Haiyan Zhao (St. Louis, Missouri);  Adrianus Boon (St. Louis, Missouri);  Sean Whelan (St. Louis, Missouri);  Andrew McCluskey (Holden, Massachusetts);  Christopher Negron (Worcester, Massachusetts)
ABSTRACT The present invention relates to antibodies or antigen-binding fragments that are useful for treating coronavirus infections (e.g., COVID-19 caused by SARS-CoV-2). The present invention also relates to various pharmaceutical compositions and methods of treating coronavirus using the antibodies or antigen-binding fragments.
FILED Friday, April 16, 2021
APPL NO 17/232796
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/215 (20130101)
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)

Peptides
C07K 16/10 (20130101) Original (OR) Class
C07K 2317/24 (20130101)
C07K 2317/76 (20130101)
C07K 2317/92 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018045 Lundin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Secretary of the Army (SECARMY)
Department of the Navy (DON)
Secretary of the Navy (SECNAV)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia);  The United States of America, as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Jeffrey G. Lundin (Burke, Virginia);  Justin Ryan, III (Chapel Hill, North Carolina);  Riccardo Casalini (Hyattsville, Maryland);  Joshua Alan Orlicki (Havre de Grace, Maryland)
ABSTRACT Disclosed herein are fibers having a polymer, such as a textile polymer, and an insect repellant, such as picaridin. The fiber may have a core of the polymer and repellant surrounded by a sheath of the polymer. The fiber may be made by electrospinning a solution of the polymer and the repellant.
FILED Friday, July 16, 2021
APPL NO 17/377795
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/34 (20130101)
A01N 43/40 (20130101)

Crimping or Curling Fibres, Filaments, Threads, or Yarns; Yarns or Threads
D02G 3/36 (20130101) Original (OR) Class

Indexing Scheme Associated With Sublasses of Section D, Relating to Textiles
D10B 2331/021 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018377 Travis et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (, None)
INVENTOR(S) Robert D. Travis (Tucson, Arizona);  Justin Powell (Tucson, Arizona)
ABSTRACT A frangible detent pin comprising a base a pin head and an elastic member. The base is configured to be secured within a bore. The pin head and the base are interconnected through a frangible connection. The elastic member is configured to bias the pin head away from the base. The frangible detent pin has a rigid stage in which the pin head is rigidly positioned relative to the base and a spring-loaded stage in which the pin head is moveable relative to the base under a compression load between pin head and the base. The frangible detent pin is configured to transition from the rigid stage to the spring-loaded stage in response to the compression load exceeding a predetermined threshold sufficient to cause the frangible connection to fail.
FILED Wednesday, July 15, 2020
APPL NO 16/930233
CURRENT CPC
Devices for Fastening or Securing Constructional Elements or Machine Parts Together, e.g Nails, Bolts, Circlips, Clamps, Clips, Wedges, Joints or Jointing
F16B 19/002 (20130101)
F16B 31/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018624 Seghi et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Surface Warfare Center (NSWC)
Secretary of the Navy (SECNAV)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Crane, Indiana)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) Steven Seghi (Bloomington, Indiana);  Kevin Kellar (Crane, Indiana)
ABSTRACT The invention relates to quick acting interfaces that allow for easier transportation and maintenance of precision rifles. Embodiments include an interface with an engaging segment and a receiving segment that engage one another and lock together. The engaging segment may have a series of connective bearings that fit into indentations inside the receiving segment. Embodiments allow a firearm to be modulated such that a barrel of the firearm may be disassembled without the need of any specialized equipment and reassembled without impacting the firearm's accuracy or reliability. Embodiments are scalable such that multiple interfaces can be used to adjust the total length of the firearm barrel.
FILED Tuesday, March 16, 2021
APPL NO 17/202819
CURRENT CPC
Functional Features or Details Common to Both Smallarms and Ordnance, e.g Cannons; Mountings for Smallarms or Ordnance
F41A 21/482 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018746 Liu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Flex Ltd. (Singapore, Singapore)
ASSIGNEE(S)
INVENTOR(S) Weifeng Liu (Dublin, California);  Jesus A. Tan (Fremont, California);  William L. Uy (San Jose, California);  Dongkai Shangguan (San Jose, California)
ABSTRACT Methods, devices, and systems for testing the flexibility of a sample such as an electronic device are provided herein. A testing system can have a motor operably connected to a mandrel such that the motor causes the mandrel to accurately and precisely rotate and cause the sample to conform to an outer surface of the mandrel. Moreover, a proximal end of the sample is secured to the outer surface of the mandrel, and the opposing distal end is controlled by a retractable holder such that the entire sample is subjected to a constant bend radius as the mandrel rotates. Other aspects and features such as controlling the environment around the mandrel and securing small samples to the mandrel are also described herein.
FILED Wednesday, October 07, 2020
APPL NO 17/065403
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 3/02 (20130101)
G01N 3/20 (20130101) Original (OR) Class
G01N 2203/0023 (20130101)
G01N 2203/0037 (20130101)
G01N 2203/0058 (20130101)
G01N 2203/0222 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018786 Wilson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Secretary of the Army (SECARMY)
APPLICANT(S) United States of America as Represented by The Secretary of the Army (Alexandria, Virginia)
ASSIGNEE(S)
INVENTOR(S) Rebekah C Wilson (Mahomet, Illinois);  Benjamin C Masters (Urbana, Illinois)
ABSTRACT Disclosed are methods that, by not physically touching a material being measured, can measure the material's differential response quite accurately. A collimated light shines on the material under test, is reflected off it, and is then captured by a device that records the position where the reflected light is captured. This process is done both before and after the material is processed in some way (e.g., by applying a coat of paint). The change in position where the reflected light is captured is used in calculating the deflection of the material as induced b the process. This measured induced deflection is then used to accurately determinate the stress introduced into the material by the process. Other characteristics of the material under test, such as aspects of the material composition of a bi-metallic strip, for example, may also be determined from a deflection measurement.
FILED Wednesday, September 29, 2021
APPL NO 17/488320
CURRENT CPC
Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, or Fluid Pressure
G01L 1/24 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/86 (20130101) Original (OR) Class
G01N 21/8422 (20130101)
G01N 2021/8438 (20130101)
G01N 2021/8636 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019020 Popovic
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) The Regents of the University of Colorado, a body corporate (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Milos A. Popovic (Boulder, Colorado)
ABSTRACT A grating coupler couples a waveguide to a beam and is formed of patterned shapes in a first and second layer of planar material, the shapes embedded in background material, the layers separated by less than one wavelength. The shapes are organized as a plurality of adjacent unit cells arranged along a direction of propagation of light with each unit cell including a shape of the first material and a shape of the second material, each unit cell having design parameters including a period, a width wb of the shape of first planar material, a width wt of the shape of second planar material, and an offset between the shapes. The coupler has a directivity ratio D is at least 10 dB between “up” and “down” radiation; and unit cells differ in at least one parameter selected from period, wb, wt, and offset to provide a predetermined beam shape.
FILED Friday, April 16, 2021
APPL NO 17/232677
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/34 (20130101)
G02B 6/124 (20130101) Original (OR) Class
G02B 6/305 (20130101)
G02B 6/1228 (20130101)
G02B 27/4266 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 27/1203 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019048 Hall et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Secretary of the Air Force (SECAF)
APPLICANT(S) Government of the United States, as represented by the Secretary of the Air Force (Wright-patterson AFB, Ohio)
ASSIGNEE(S)
INVENTOR(S) Harris J Hall (Yellow Springs, Ohio);  David Torres Reyes (Mason, Ohio);  Michael E McConney (Dayton, Ohio)
ABSTRACT A tunable optical filter for a detector is presented including a plate having a top side and a bottom side. The plate has material properties making it transparent to a range of optical frequencies. A transparent metasurface is proximate the top side of the plate. The transparent metasurface is configured to have a transmissive pass band and a stop band. An undercarriage support structure is proximate the bottom side of the plate. The undercarriage support is responsive to photothermal heating. The undercarriage support is configured to deform from the photothermal heating caused by an undesired signal thereby shifting the stop band in frequency toward the undesired signal to block reception of the undesired signal by the detector.
FILED Monday, July 20, 2020
APPL NO 16/933078
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/29359 (20130101)
G02B 7/008 (20130101) Original (OR) Class
G02B 7/1815 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019514 Gu et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
National Science Foundation (NSF)
APPLICANT(S) Ronghui Gu (New York, New York);  Jason Nieh (New York, New York);  Runzhou Tao (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Ronghui Gu (New York, New York);  Jason Nieh (New York, New York);  Runzhou Tao (New York, New York)
ABSTRACT Mechanisms for proving the correctness of software on relaxed memory hardware are provided, the mechanisms comprising: receiving a specification, a hardware model, and an implementation for the software to be executed on the relaxed memory hardware; evaluating the software using a sequentially consistent hardware model; evaluating the software using a relaxed memory hardware model and at least one of the following conditions: a data-race-free (DRF)-kernel condition; a no-barrier-misuse condition; a memory-isolation condition; a transactional-page-table condition; a write-once-kernel-mapping condition; and a weak-memory-isolation condition; and outputting an indication of whether the software is correct based on the evaluating the software using the sequentially consistent hardware model and the evaluating the software using the relaxed memory hardware model.
FILED Wednesday, July 14, 2021
APPL NO 17/376120
CURRENT CPC
Electric Digital Data Processing
G06F 11/3604 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019545 BERTACCO et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
INVENTOR(S) Valeria BERTACCO (Ann Arbor, Michigan);  Abraham ADDISIE (Ann Arbor, Michigan)
ABSTRACT The increased use of graph algorithms in diverse fields has highlighted their inefficiencies in current chip-multiprocessor (CMP) architectures, primarily due to their seemingly random-access patterns to off-chip memory. Here, a novel computer memory architecture is proposed that processes operations on vertex data in on-chip memory and off-chip memory. The hybrid computer memory architecture utilizes a vertex's degree as a proxy to determine whether to process related operations in on-memory or off-chip memory. The proposed computer memory architecture manages to provide up to 4.0× improvement in performance and 3.8× in energy benefits, compared to a baseline CMP, and up to a 2.0× performance boost over state-of-the-art specialized solutions.
FILED Friday, July 17, 2020
APPL NO 16/932183
CURRENT CPC
Electric Digital Data Processing
G06F 13/1668 (20130101) Original (OR) Class
G06F 13/4027 (20130101)
G06F 13/4282 (20130101)
G06F 16/9558 (20190101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019580 Mirhaji
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S)
INVENTOR(S) Parsa Mirhaji (Pearland, Texas)
ABSTRACT Embodiments of methods and systems for informatics systems are disclosed. Such informatics systems may utilize a unifying format to represent text to facilitate linking between data from the text and one or more ontologies, and the commensurate ability to mine such data.
FILED Wednesday, September 29, 2021
APPL NO 17/489533
CURRENT CPC
Electric Digital Data Processing
G06F 16/22 (20190101)
G06F 16/248 (20190101)
G06F 16/367 (20190101)
G06F 16/2465 (20190101) Original (OR) Class
G06F 16/3329 (20190101)
G06F 16/3344 (20190101)
G06F 16/9024 (20190101)
G06F 40/211 (20200101)
G06F 40/253 (20200101)
G06F 40/284 (20200101)
G06F 40/289 (20200101)

Computer Systems Based on Specific Computational Models
G06N 5/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019657 Sethumadhavan et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Lakshminarasimhan Sethumadhavan (Niskayuna, New York);  Miguel Arroyo (New York, New York);  Mohamed Tarek Bnziad Mohamed Hassan (New York, New York);  Evgeny Manzhosov (New York, New York)
ABSTRACT Disclosed are methods, systems, devices, media, circuits, and other implementations, including a method that includes generating for a code block of a process executing on a controller-based device one or more code block copies defined in a virtual address space of the controller-based device, with the code block of the process being stored in a particular segment of a physical address space of the controller-based device, and with the code block configured to separately map to each of the one or more of the code block copies in the virtual address space. The method further includes processing at least a portion of one of the one or more code block copies defined in the virtual address space when the corresponding code block of the process is to be processed.
FILED Thursday, September 24, 2020
APPL NO 17/030785
CURRENT CPC
Electric Digital Data Processing
G06F 21/53 (20130101)
G06F 21/54 (20130101) Original (OR) Class
G06F 2221/2135 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019716 Kiarashinejad et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Yashar Kiarashinejad (Atlanta, Georgia);  Sajjad Abdollahramezani (Atlanta, Georgia);  Ali Adibi (Atlanta, Georgia)
ASSIGNEE(S)
INVENTOR(S) Yashar Kiarashinejad (Atlanta, Georgia);  Sajjad Abdollahramezani (Atlanta, Georgia);  Ali Adibi (Atlanta, Georgia)
ABSTRACT Disclosed are systems and method for enhanced engineering design and optimization incorporating double-step dimensionality-reduction in order to provide customized, automated solutions to the design and optimization of electromagnetic nanostructures. The system can train a multi-stage neural network reduce the response space of a design problem. The system can train a second neural network to reduce the design space of the design problem. As a result of these reductions, the system can generate a one-to-one relationship between the design and response spaces of complex design problems. The system can subsequently solve both the forward design and the inverse problem. Additionally, the system can utilize the generated neural networks to determine a plurality of analytical relationships between the design space and the response space. The system can then utilize the determined relationship to arrive at optimal design solutions.
FILED Wednesday, November 20, 2019
APPL NO 17/294837
CURRENT CPC
Electric Digital Data Processing
G06F 30/27 (20200101) Original (OR) Class

Computer Systems Based on Specific Computational Models
G06N 3/084 (20130101)
G06N 3/088 (20130101)
G06N 3/0454 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019787 Diienno
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Secretary of the Army (SECARMY)
APPLICANT(S) The Government of the United States, as represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Robert Diienno (Avondale, Pennsylvania)
ABSTRACT Various embodiments are described that relate to classification of an unknown object. A time series signal associated with an unknown object can be obtained from a sensor. The time series signal can be subjected to a transform set, such as a Fourier transform and a discrete cosine transform, to produce a transform outcome. Based, at least in part, on the transform outcome, the unknown object can be classified.
FILED Tuesday, July 14, 2020
APPL NO 16/928280
CURRENT CPC
Electric Digital Data Processing
G06F 17/147 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00536 (20130101) Original (OR) Class
G06K 9/6202 (20130101)
G06K 9/6268 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020635 Mohseni et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
United States Army (USA)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Hooman Mohseni (Wilmette, Illinois);  Simone Bianconi (Evanston, Illinois)
ABSTRACT Methods for creating a conductive feature in a dielectric material are provided. In an embodiment, such a method comprises irradiating a region of a dielectric material having a resistivity of at least 108 W cm with a focused ion beam, the irradiated region corresponding to a conductive feature embedded in the dielectric material, the conductive feature having a conductivity greater than that of the dielectric material; and forming one or more contact pads of a conductive material in electrical communication with the conductive feature, the one or more contact pads configured to apply a voltage across the conductive feature using a voltage source.
FILED Thursday, November 07, 2019
APPL NO 17/293276
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/42 (20130101)
H01L 21/76823 (20130101) Original (OR) Class
H01L 21/76825 (20130101)
H01L 21/76843 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020914 Shabani et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) NEW YORK UNIVERSITY (New York, New York)
ASSIGNEE(S) NEW YORK UNIVERSITY (New York, New York)
INVENTOR(S) Javad Shabani (Briarcliff Manor, New York);  Matthieu C. Dartiailh (New York, New York)
ABSTRACT The method of performing braiding operations can include providing a first Josephson junction including first gates. The method can include providing a second Josephson junction including second gates. The method can include tuning the first gates to dispose a first pair of Majorana fermions a first region. The method can include tuning the second gates to dispose a second pair of Majorana fermions in a second region. The method can include tuning the first gates to dispose a first Majorana fermion in the first region and to dispose a second Majorana fermion in a third region. The method can include tuning the second gates to dispose a third Majorana fermion in a fourth region and to dispose a fourth Majorana fermion in the second region.
FILED Friday, July 16, 2021
APPL NO 17/378375
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 39/223 (20130101) Original (OR) Class
H01L 39/228 (20130101)
H01L 39/2493 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020942 Colbert et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Research Laboratory (NRL)
Secretary of the Navy (SECNAV)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) Adam E. Colbert (Alexandria, Virginia);  Diogenes Placencia (Alexandria, Virginia);  Janice E. Boercker (Fairfax, Virginia);  Edward E. Aifer (Arlington, Virginia);  Joseph G. Tischler (Alexandria, Virginia);  Erin L. Ratcliff (Tucson, Arizona)
ABSTRACT Photodiodes configured to convert incident photons in the short-wave infrared (SWIR) to electric current, where the photodiodes have a PbS/PbClx core/shell nanocrystal absorber layer. The PbClx shell in the PbS/PbClx nanocrystals provide native passivation in the (100) crystal facets and enable removal of native ligands and ligand exchange on the (111) crystal facets of the PbS/PbClx nanocrystals such that the photodiode exhibits reduced current densities under reverse bias and greater infrared photoresponse, providing improved device performance as compared to photodiodes having absorber layers formed from PbS core nanocrystals alone.
FILED Wednesday, July 14, 2021
APPL NO 17/375050
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0077 (20130101)
H01L 51/426 (20130101)
H01L 51/447 (20130101) Original (OR) Class
H01L 51/4293 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021216 Perry et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Research, Development and Engineering Command (RDECOM)
APPLICANT(S) DEKA Products Limited Partnership (Manchester, New Hampshire)
ASSIGNEE(S)
INVENTOR(S) N. Christopher Perry (Manchester, New Hampshire);  Stewart M. Coulter (Bedford, New Hampshire);  Thomas A. Doyon (Manchester, New Hampshire)
ABSTRACT A system for powering a device is disclosed. The system includes at least one internal battery located in a device, at least one external battery connected to the device, and a master controller configured to connect either the at least one internal battery or the at least one external battery to a power bus to power the device.
FILED Friday, October 01, 2021
APPL NO 17/491660
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 31/382 (20190101)

Electric Digital Data Processing
G06F 1/263 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 10/425 (20130101)
H01M 10/482 (20130101)
H01M 10/4207 (20130101)

Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 3/38 (20130101) Original (OR) Class
H02J 7/0013 (20130101)
H02J 7/0068 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021391 PASANDI et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California)
ASSIGNEE(S)
INVENTOR(S) Ghasem PASANDI (Los Angeles, California);  Massoud PEDRAM (Beverly Hills, California)
ABSTRACT An SFQ circuit system includes at least one SFQ block having a plurality of SFQ logic gates. Characteristically, at least a portion of the SFQ logic gates are arranged in series. The SFQ circuit system includes a timing system configured to provide a first set of inputs and collect a first set of outputs of the at least one SFQ block at a rate defined by a slow clock frequency while the SFQ logic gates are clocked at a fast clock frequency. Advantageously, the rate is sufficiently slow to allow the first set of inputs to propagate through all levels of the SFQ logic gates to produce the first set of outputs of the at least one SFQ block without colliding with a second set of inputs to the at least one SFQ block.
FILED Monday, April 05, 2021
APPL NO 17/221998
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101)

Pulse Technique
H03K 19/20 (20130101)
H03K 19/096 (20130101)
H03K 19/195 (20130101) Original (OR) Class
H03K 19/17744 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021464 Beun
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Research Laboratory (NRL)
Secretary of the Navy (SECNAV)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
ASSIGNEE(S)
INVENTOR(S) Josh Beun (Alexandria, Virginia)
ABSTRACT A finite rate of innovation (FRI) communications system includes a reference signal generator, an FRI modulator configured to apply an FRI kernel and encode information onto the reference signal, and a transmitter configured to transmit the encoded signal. The FRI kernel is one of a sinc function kernel or a Gaussian kernel. A receiver unit is configured to receive an encoded signal, convert the encoded signal into a digital signal, and demodulate and recover information from finite rate of innovation parameters in the digital signal.
FILED Wednesday, July 14, 2021
APPL NO 17/376083
CURRENT CPC
Electric Digital Data Processing
G06F 7/548 (20130101)

Transmission
H04B 10/50 (20130101)
H04B 10/60 (20130101) Original (OR) Class

Transmission of Digital Information, e.g Telegraphic Communication
H04L 5/0048 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021620 Halepovic et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
National Science Foundation (NSF)
APPLICANT(S) AT and T INTELLECTUAL PROPERTY I, L.P. (Atlanta, Georgia);  THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Illinois)
ASSIGNEE(S)
INVENTOR(S) Emir Halepovic (Somerset, New Jersey);  Vijay Gopalakrishnan (Edison, New Jersey);  Muhammad Usama Chaudhry (Milpitas, California);  Shanyu Zhou (Chicago, Illinois);  Balajee Vamanan (Chicago, Illinois);  Hulya Seferoglu (Chicago, Illinois)
ABSTRACT In various aspects, a system that comprises detecting a congestion event in a network that transmits a first group of data packets and a second group of data packets, wherein the detecting the congestion event comprises detecting the congestion event has initiated in response to a data packet throughput value of the network having been determined to have decreased below a threshold value; in response to the detecting of the congestion event, determine a transmission rate of the second group of data packets based on a transmission priority of the second group of data packets; determining a data packet dropping rate for the second group of data packets based on the transmission rate of the second group of data packets and a size of the first group of data packets and transmitting the second group of data packets utilizing the transmission rate and the data packet dropping rate.
FILED Friday, October 01, 2021
APPL NO 17/492351
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 43/062 (20130101)
H04L 43/0829 (20130101)
H04L 43/0894 (20130101)
H04L 47/24 (20130101) Original (OR) Class
H04L 47/6215 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021710 Eskridge et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Raytheon BBN Technologies Corp. (Cambridge, Massachusetts);  Florida Institute of Technology, Inc. (Melbourne, Florida)
ASSIGNEE(S) Raytheon BBN Technologies Corp. (Cambridge, Massachusetts);  Florida Institute of Technology, Inc. (Melbourne, Florida)
INVENTOR(S) Thomas C. Eskridge (Satellite Beach, Florida);  Marco M. Carvalho (Satellite Beach, Florida);  Brett Benyo (Ayer, Massachusetts);  Michael Atighetchi (Framingham, Massachusetts);  Fusun Yaman (Arlington, Massachusetts)
ABSTRACT A decision engine includes: a genetic algorithm framework including a knowledge base of standard configurations, a candidate selector generator and a selector to select a candidate configuration from a plurality of preferred standard configurations in response to the candidate selector generator; a parallelized reasoning framework including an attack surface reasoning algorithm module to compute the security and cost tradeoffs of an attack surface associated with each candidate configuration; and a user interface framework including a web service engine where users can interact and provide feedback on direction of an evolution used in a genetic algorithm search for evolving defenses.
FILED Wednesday, July 14, 2021
APPL NO 17/375580
CURRENT CPC
Electric Digital Data Processing
G06F 16/2423 (20190101)

Computer Systems Based on Specific Computational Models
G06N 3/126 (20130101)
G06N 5/022 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 41/08 (20130101)
H04L 41/22 (20130101)
H04L 63/20 (20130101) Original (OR) Class
H04L 63/1433 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220022044 D'ORO et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) Northeastern University (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Salvatore D'ORO (Allston, Massachusetts);  Tommaso MELODIA (Newton, Massachusetts);  Francesco RESTUCCIA (Boston, Massachusetts);  Leonardo BONATI (Boston, Massachusetts)
ABSTRACT Methods and systems are provided for allocating resources to users in a wireless network including a plurality of edge nodes that provide wireless network access and multi-access edge computing functions. Slice requests are received from the users for a type of resource, including one or more of networking resources, storage resources, and computation resources. A set of slice requests to be admitted is determined based on resource availability constraints among one or more of the networking resources, the storage resources, and the computation resources at each edge node.
FILED Thursday, July 01, 2021
APPL NO 17/365070
CURRENT CPC
Wireless Communication Networks
H04W 4/021 (20130101)
H04W 16/10 (20130101) Original (OR) Class
H04W 16/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220022287 Pirlo et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Secretary of the Navy (SECNAV)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) Russell Kirk Pirlo (Oakwood, Ohio);  Joel D. Gaston (Alexandria, Virginia)
ABSTRACT A device having: an article having a flat surface and a lower surface opposed to the flat surface; a cavity formed in the lower surface forming a complete loop surrounding a central portion of the article; a heating element having the same shape as the complete loop in the cavity and positioned to warm a portion of the flat surface adjacent to the heating element when the heating element is activated; a cooling device positioned to cool a portion of the flat surface in the central portion; and a release layer on the flat surface. A device having: an article having an upper surface; a heating element on the upper surface forming a complete loop surrounding a central portion of the article; and an electrically insulating material on the upper surface within the central portion.
FILED Wednesday, September 29, 2021
APPL NO 17/488738
CURRENT CPC
Mechanical Methods or Apparatus in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons
D01D 5/0015 (20130101)
D01D 5/0061 (20130101)
D01D 5/0076 (20130101)

Electric Heating; Electric Lighting Not Otherwise Provided for
H05B 3/40 (20130101) Original (OR) Class
H05B 3/64 (20130101)
H05B 2213/03 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 20220015500 Pretzer-Aboff et al.
FUNDED BY
National Science Foundation (NSF)
Office of Experimental Program To Stimulate Competitive Research (EPSCOR)
APPLICANT(S) Ingrid Pretzer-Aboff (Newark, Delaware);  Richard D. Martin (Newark, Delaware);  David Bruce Chase (Newark, Delaware);  Scott Jones (Newark, Delaware);  John F. Rabolt (Greenville, Delaware)
ASSIGNEE(S) University of Delaware (Newark, Delaware)
INVENTOR(S) Ingrid Pretzer-Aboff (Newark, Delaware);  Richard D. Martin (Newark, Delaware);  David Bruce Chase (Newark, Delaware);  Scott Jones (Newark, Delaware);  John F. Rabolt (Greenville, Delaware)
ABSTRACT A device adapted to be secured to the foot of a user includes one or more vibration actuators configured to provide vibrations to the user's foot, one or more force or acceleration sensors configured to sense forces or acceleration exerted by the user's foot, and a controller configured to operate the vibration actuators in a continuous mode to provide intermittent vibration to the user's foot independent of information sensed by the force or acceleration sensors. The vibration includes a first period of continuous vibration followed by a second period of no vibration followed by a third period of continuous vibration. The device may also be configured to operate in a feedback mode.
FILED Thursday, December 12, 2019
APPL NO 17/413337
CURRENT CPC
Characteristic Features of Footwear; Parts of Footwear
A43B 3/0005 (20130101)
A43B 7/147 (20130101) Original (OR) Class

Physical Therapy Apparatus, e.g Devices for Locating or Stimulating Reflex Points in the Body; Artificial Respiration; Massage; Bathing Devices for Special Therapeutic or Hygienic Purposes or Specific Parts of the Body
A61H 3/00 (20130101)
A61H 23/02 (20130101)
A61H 2201/165 (20130101)
A61H 2201/1642 (20130101)
A61H 2201/5061 (20130101)
A61H 2201/5084 (20130101)
A61H 2201/5097 (20130101)
A61H 2205/12 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 20/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220015832 DiMaio et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
National Science Foundation (NSF)
APPLICANT(S) Intuitive Surgical Operations, Inc. (Sunnyvale, California);  The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Simon P. DiMaio (San Carlos, California);  Christopher J. Hasser (Los Altos, California);  Russell H. Taylor (Severna Park, Maryland);  David Q. Larkin (Menlo Park, California);  Peter Kazanzides (Towson, Maryland);  Anton Deguet (Baltimore, Maryland);  Balazs Peter Vagvolgyi (Baltimore, Maryland);  Joshua Leven (San Francisco, California)
ABSTRACT A minimally invasive surgical system is disclosed including a processor coupled to a stereoscopic endoscope and a stereoscopic video display device. The processor generates an operative image of an anatomic structure in the surgical site, overlays the operative image onto the captured stereo video images for display on the stereoscopic video display device, generates and overlays a pointer onto the operative image or the captured stereo video images to display the pointer on the stereoscopic video display device with a three dimensional appearance, and switches between a first mode for input devices of a surgeon console used to couple motion into surgical instruments and a second mode used to control an interactive graphical user interface to allow interactions with the pointer and the operative image in three dimensions using input devices having at least three degrees of freedom.
FILED Tuesday, September 07, 2021
APPL NO 17/468198
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 1/00193 (20130101)
A61B 8/00 (20130101)
A61B 8/12 (20130101)
A61B 8/4245 (20130101)
A61B 34/10 (20160201) Original (OR) Class
A61B 34/30 (20160201)
A61B 34/37 (20160201)
A61B 34/70 (20160201)
A61B 34/71 (20160201)
A61B 34/76 (20160201)
A61B 2017/00203 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016612 Zhao
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Iowa State University Research Foundation, Inc. (Ames, Iowa)
ASSIGNEE(S)
INVENTOR(S) Yan Zhao (Ames, Iowa)
ABSTRACT The disclosure relates to molecularly-imprinted cross-linked micelles that can selectively hydrolyze carbohydrates.
FILED Tuesday, July 06, 2021
APPL NO 17/368257
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/067 (20130101) Original (OR) Class
B01J 35/0013 (20130101)
B01J 37/04 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 1/00 (20130101)

Polysaccharides; Derivatives Thereof
C08B 15/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016626 Chiou et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Pei-Yu E. Chiou (Los Angeles, California);  Kuo-Wei Huang (Los Angeles, California);  Igor Y. Khandros (Orinda, California);  Ming C. Wu (Moraga, California)
ABSTRACT Microfluidic devices in which electrokinetic mechanisms move droplets of a liquid or particles in a liquid are described. The devices include at least one electrode that is optically transparent and/or flexible.
FILED Friday, August 13, 2021
APPL NO 17/401478
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502715 (20130101) Original (OR) Class
B01L 2300/123 (20130101)
B01L 2300/165 (20130101)
B01L 2400/0415 (20130101)
B01L 2400/0424 (20130101)
B01L 2400/0427 (20130101)
B01L 2400/0638 (20130101)

Magnetic or Electrostatic Separation of Solid Materials From Solid Materials or Fluids; Separation by High-voltage Electric Fields
B03C 5/005 (20130101)
B03C 5/026 (20130101)
B03C 2201/26 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/44791 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017418 Akono et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Ange-Therese Akono (Evanston, Illinois);  Jiaxin Chen (Evanston, Illinois)
ABSTRACT Methods for the dispersion and synthesis of multi-walled carbon nanotube-cement composites with high concentrations of multi-walled carbon nanotubes that do not require chemical dispersion aids or dispersion-enhancing chemical surface functionalization are provided. Also provided are multi-walled carbon nanotube-cement composites made using the methods. Methods for the dispersion and synthesis of carbon nanofiber-cement composites with high concentrations of carbon nanofibers that do not require chemical dispersion aids or dispersion-enhancing chemical surface functionalization are further provided. Also provided are carbon nanofiber-cement composites made using the methods.
FILED Thursday, July 15, 2021
APPL NO 17/376426
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 14/026 (20130101)
C04B 14/386 (20130101)
C04B 28/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017556 Pemberton et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (TUCSON, Arizona)
ASSIGNEE(S) ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (Tucson, Arizona)
INVENTOR(S) Jeanne E. Pemberton (Tucson, Arizona);  Tyler Roberts (Tucson, Arizona)
ABSTRACT The present disclosure discusses methods for producing stereoisomerically enriched carbohydrate-based surfactants. In particular, methods of the invention include producing stereoisomerically enriched hydrophobic portion of the carbohydrate-based surfactants.
FILED Wednesday, September 29, 2021
APPL NO 17/489477
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 3/003 (20130101)
C07F 9/94 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 1/00 (20130101)
C07H 15/04 (20130101)
C07H 15/06 (20130101)
C07H 15/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018060 Subramaniam et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Directorate for Education and Human Resources (EHR)
Division of Human Resource Development (HRD)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Anand Bala Subramaniam (Merced, California);  Joseph Pazzi (Merced, California);  Vaishnavi Girish (Merced, California)
ABSTRACT Methods and compositions for rapid and efficient assembly of fibers coated with lamellar vesicles are provided. Cosmetic and therapeutic uses of vesicle-coated fibers are also provided.
FILED Thursday, November 14, 2019
APPL NO 17/293905
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/1272 (20130101)
A61K 9/1273 (20130101)
A61K 9/1277 (20130101)

Treatment, Not Provided for Elsewhere in Class D06, of Fibres, Threads, Yarns, Fabrics, Feathers or Fibrous Goods Made From Such Materials
D06M 13/203 (20130101)
D06M 15/647 (20130101)
D06M 23/02 (20130101) Original (OR) Class

Pulp Compositions; Preparation Thereof Not Covered by Subclasses D21C or D21D; Impregnating or Coating of Paper; Treatment of Finished Paper Not Covered by Class B31 or Subclass D21G; Paper Not Otherwise Provided for
D21H 19/82 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018826 Rege et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (Scottsdale, Arizona);  BANNER HEALTH (Phoenix, Arizona)
ASSIGNEE(S) ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (Scottsdale, Arizona);  BANNER HEALTH (Phoenix, Arizona)
INVENTOR(S) Kaushal Rege (Chandler, Arizona);  Karthik Subramaniam Pushpavanam (Tempe, Arizona);  Eshwaran Narayanan (Tempe, Arizona);  Stephen Sapareto (Apache Junction, Arizona);  John C. Chang (Gilbert, Arizona)
ABSTRACT An apparatus includes a solution including a metallic compound, a surfactant, and an acid. The solution is substantially colorless. A container holds the solution. A radiated solution is formed when the solution receives a low dose of ionizing radiation
FILED Thursday, June 24, 2021
APPL NO 17/357138
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/02 (20130101)
G01N 33/48 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019020 Popovic
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) The Regents of the University of Colorado, a body corporate (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Milos A. Popovic (Boulder, Colorado)
ABSTRACT A grating coupler couples a waveguide to a beam and is formed of patterned shapes in a first and second layer of planar material, the shapes embedded in background material, the layers separated by less than one wavelength. The shapes are organized as a plurality of adjacent unit cells arranged along a direction of propagation of light with each unit cell including a shape of the first material and a shape of the second material, each unit cell having design parameters including a period, a width wb of the shape of first planar material, a width wt of the shape of second planar material, and an offset between the shapes. The coupler has a directivity ratio D is at least 10 dB between “up” and “down” radiation; and unit cells differ in at least one parameter selected from period, wb, wt, and offset to provide a predetermined beam shape.
FILED Friday, April 16, 2021
APPL NO 17/232677
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/34 (20130101)
G02B 6/124 (20130101) Original (OR) Class
G02B 6/305 (20130101)
G02B 6/1228 (20130101)
G02B 27/4266 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 27/1203 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019434 Gu et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Jie Gu (Evanston, Illinois);  Zhengyu Chen (Evanston, Illinois)
ABSTRACT Systems and/or methods can include a ring based inverter chain that constructs multi-bit flip-flops that store time. The time flip-flops serve as storage units and enable pipeline operations. Single cells used in time series analysis, such as dynamic time warping are rendered by the time-domain circuits. The circuits include time flip-flops, Min, and ABS circuits. A and the matrix can be constructed through the single cells.
FILED Wednesday, December 18, 2019
APPL NO 17/311849
CURRENT CPC
Electric Digital Data Processing
G06F 7/605 (20130101)
G06F 9/3001 (20130101)
G06F 9/3555 (20130101)
G06F 9/30029 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019441 Rosing et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Tajana Simunic Rosing (San Diego, California);  Justin Morris (San Diego, North Carolina);  Mohsen Imani (San Diego, California);  Yeseong Kim (La Jolla, California);  John Messerly (Danville, California);  Yunhui Guo (San Diego, California);  Behnam Khaleghi (La Jolla, California);  Saransh Gupta (La Jolla, California);  Sahand Salamat (San Diego, California);  Joonseop Sim (San Diego, California)
ABSTRACT A hyperdimensional processing system can be configured to process hyperdimensional (HD) data, where the system can include a CPU configured to receive compiled binary executable data including CPU native instructions and hyperdimensional processing unit (HPU) native instructions, wherein the CPU is configured to store the CPU native instructions in a main memory coupled to the CPU for retrieval and execution by the CPU, the CPU further configured to forward the HPU native instructions to a HPU. The HPU can be configured to receive HPU native instructions native instructions and to store the HPU native instructions in a hyperdimensional memory coupled to the HPU for retrieval and execution by the CPU. Other aspects and embodiments according to the present invention are also disclosed herein.
FILED Wednesday, July 14, 2021
APPL NO 17/376105
CURRENT CPC
Electric Digital Data Processing
G06F 9/3836 (20130101) Original (OR) Class
G06F 9/30036 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/063 (20130101)

Static Stores
G11C 13/0026 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019514 Gu et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
National Science Foundation (NSF)
APPLICANT(S) Ronghui Gu (New York, New York);  Jason Nieh (New York, New York);  Runzhou Tao (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Ronghui Gu (New York, New York);  Jason Nieh (New York, New York);  Runzhou Tao (New York, New York)
ABSTRACT Mechanisms for proving the correctness of software on relaxed memory hardware are provided, the mechanisms comprising: receiving a specification, a hardware model, and an implementation for the software to be executed on the relaxed memory hardware; evaluating the software using a sequentially consistent hardware model; evaluating the software using a relaxed memory hardware model and at least one of the following conditions: a data-race-free (DRF)-kernel condition; a no-barrier-misuse condition; a memory-isolation condition; a transactional-page-table condition; a write-once-kernel-mapping condition; and a weak-memory-isolation condition; and outputting an indication of whether the software is correct based on the evaluating the software using the sequentially consistent hardware model and the evaluating the software using the relaxed memory hardware model.
FILED Wednesday, July 14, 2021
APPL NO 17/376120
CURRENT CPC
Electric Digital Data Processing
G06F 11/3604 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020896 Brown et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Wright State University (Dayton, Ohio)
ASSIGNEE(S)
INVENTOR(S) Elliott R. Brown (Beavercreek, Ohio);  Weidong Zhang (Cary, North Carolina);  Tyler Growden (Dublin, Ohio);  Paul Berger (Columbus, Ohio)
ABSTRACT A unipolar-doped light emitting diode or laser diode is described. The diode includes a bottom region having an n-type layer, a top region having an n-type layer, and a middle region between the top and bottom regions having at least one material different from the top or bottom region forming two or more heterojunctions. The top and bottom regions create light emission by interband tunneling-induced photon emission. Systems including the unipolar-doped diode including LIDAR are also taught.
FILED Wednesday, October 28, 2020
APPL NO 17/083286
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 33/06 (20130101)
H01L 33/0025 (20130101) Original (OR) Class
H01L 33/0029 (20130101)
H01L 33/145 (20130101)

Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/347 (20130101)
H01S 5/0657 (20130101)
H01S 5/34313 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021110 Yoon et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) University of Florida Research Foundation, Inc. (Gainesville, Florida)
ASSIGNEE(S)
INVENTOR(S) Yong-Kyu Yoon (Gainesville, Florida);  Seahee Hwangbo (Gainesville, Florida)
ABSTRACT Various examples are provided for meander line (ML) slots, which can be used for mutual coupling reduction. In one example, an antenna array includes first and second patch antenna elements disposed on a first side of a substrate, the first and second patch antenna elements separated by a gap. The antenna array can include a meander line (ML) slot formed in a ground plane disposed on a second side of the substrate. A plurality of ML slots can be aligned with the gap between the first and second patch antenna elements. In another example, a method includes forming first and second antenna elements on a first side of a substrate and forming a ML slot in a ground plane disposed on a second side of the substrate aligned with a gap between the first and second antenna elements.
FILED Monday, May 10, 2021
APPL NO 17/315964
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 1/52 (20130101)
H01Q 1/523 (20130101) Original (OR) Class
H01Q 3/00 (20130101)
H01Q 9/0407 (20130101)
H01Q 21/06 (20130101)
H01Q 21/065 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021620 Halepovic et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
National Science Foundation (NSF)
APPLICANT(S) AT and T INTELLECTUAL PROPERTY I, L.P. (Atlanta, Georgia);  THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Illinois)
ASSIGNEE(S)
INVENTOR(S) Emir Halepovic (Somerset, New Jersey);  Vijay Gopalakrishnan (Edison, New Jersey);  Muhammad Usama Chaudhry (Milpitas, California);  Shanyu Zhou (Chicago, Illinois);  Balajee Vamanan (Chicago, Illinois);  Hulya Seferoglu (Chicago, Illinois)
ABSTRACT In various aspects, a system that comprises detecting a congestion event in a network that transmits a first group of data packets and a second group of data packets, wherein the detecting the congestion event comprises detecting the congestion event has initiated in response to a data packet throughput value of the network having been determined to have decreased below a threshold value; in response to the detecting of the congestion event, determine a transmission rate of the second group of data packets based on a transmission priority of the second group of data packets; determining a data packet dropping rate for the second group of data packets based on the transmission rate of the second group of data packets and a size of the first group of data packets and transmitting the second group of data packets utilizing the transmission rate and the data packet dropping rate.
FILED Friday, October 01, 2021
APPL NO 17/492351
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 43/062 (20130101)
H04L 43/0829 (20130101)
H04L 43/0894 (20130101)
H04L 47/24 (20130101) Original (OR) Class
H04L 47/6215 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021887 Banerjee et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S)
INVENTOR(S) Suman Banerjee (Madison, Wisconsin);  Peng Liu (Cupertino, California);  Varun Chandrasekaran (Madison, Wisconsin)
ABSTRACT A video compression/decompression system employs a machine learning model to extract regions of interest from the input video to define relatively higher bit rate portions of the video frames that are transmitted. The resulting compressed data may be transmitted using standard protocols without specialized decoders but may optionally include a second machine learning model trained at the transmitter to boost the resolution of the reconstructed compressed data emphasizing the region of interest.
FILED Tuesday, July 14, 2020
APPL NO 16/928690
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 20/00 (20190101)

Pictorial Communication, e.g Television
H04N 19/146 (20141101)
H04N 19/167 (20141101) Original (OR) Class
H04N 19/176 (20141101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220022044 D'ORO et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) Northeastern University (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Salvatore D'ORO (Allston, Massachusetts);  Tommaso MELODIA (Newton, Massachusetts);  Francesco RESTUCCIA (Boston, Massachusetts);  Leonardo BONATI (Boston, Massachusetts)
ABSTRACT Methods and systems are provided for allocating resources to users in a wireless network including a plurality of edge nodes that provide wireless network access and multi-access edge computing functions. Slice requests are received from the users for a type of resource, including one or more of networking resources, storage resources, and computation resources. A set of slice requests to be admitted is determined based on resource availability constraints among one or more of the networking resources, the storage resources, and the computation resources at each edge node.
FILED Thursday, July 01, 2021
APPL NO 17/365070
CURRENT CPC
Wireless Communication Networks
H04W 4/021 (20130101)
H04W 16/10 (20130101) Original (OR) Class
H04W 16/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 20220016598 Pang et al.
FUNDED BY
Department of Energy (DOE)
Lawrence Livermore National Laboratory (LLNL)
Lawrence Livermore National Security LLC (LLNS)
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S)
INVENTOR(S) Simon Hoching Pang (Fremont, California);  Melinda Lia Wah Jue (Livermore, California)
ABSTRACT A resin includes a functionalized aminopolymer having amine sites for capturing carbon dioxide molecules, where each aminopolymer molecule has at least one functional group amenable to crosslinking, a porogen, and a crosslinking initiator. A product includes an aminopolymer material formed into a self-supporting structure, the aminopolymer material including crosslinked aminopolymers having amine sites for the capture of carbon dioxide molecules.
FILED Tuesday, July 06, 2021
APPL NO 17/368598
CURRENT CPC
Separation
B01D 53/62 (20130101)
B01D 53/81 (20130101)
B01D 53/96 (20130101)
B01D 2253/34 (20130101)
B01D 2253/202 (20130101)
B01D 2257/504 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/267 (20130101) Original (OR) Class
B01J 20/3064 (20130101)
B01J 20/3085 (20130101)
B01J 20/3425 (20130101)
B01J 20/3483 (20130101)
B01J 20/3491 (20130101)
B01J 20/28033 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/50 (20170801)
C01B 2210/0007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016675 Kumar et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Sortera Alloys, Inc. (Forth Worth, Texas)
ASSIGNEE(S) Sortera Alloys, Inc. (Forth Worth, Texas)
INVENTOR(S) Nalin Kumar (Fort Worth, Texas);  Manuel Gerardo Garcia, JR. (Lexington, Kentucky)
ABSTRACT A material sorting system sorts materials utilizing multiple stages of classification and sorting, including a vision system that implements a machine learning system in order to identify or classify each of the materials, and Laser Induced Breakdown Spectroscopy to perform a subsequent classification and sorting of the remaining materials.
FILED Thursday, September 30, 2021
APPL NO 17/491415
CURRENT CPC
Postal Sorting; Sorting Individual Articles, or Bulk Material Fit to be Sorted Piece-meal, e.g by Picking
B07C 5/04 (20130101)
B07C 5/34 (20130101)
B07C 5/342 (20130101)
B07C 5/3422 (20130101) Original (OR) Class
B07C 2501/0054 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016829 Selter et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
Honeywell Federal Manufacturing and Technologies, LLC (FM&T)
APPLICANT(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
ASSIGNEE(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
INVENTOR(S) Thomas Matthew Selter (Blue Springs, Missouri);  Jamie Michael Messman (Leawood, Kansas)
ABSTRACT A system and method of additively manufacturing a part including electrically conductive or static dissipating fluorine-containing polymers. The method includes depositing fluorine-containing polymer additive manufacturing material onto a build platform, selectively cross-linking portions of the deposited additive manufacturing material, and curing the selectively cross-linked portions such that the part is at least one of electrically conductive and static dissipating.
FILED Thursday, September 30, 2021
APPL NO 17/490210
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/20 (20170801)
B29C 64/135 (20170801) Original (OR) Class

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2027/12 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 30/00 (20141201)
B33Y 70/00 (20141201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016856 Kiefer et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
Honeywell Federal Manufacturing and Technologies, LLC (FM&T)
APPLICANT(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
ASSIGNEE(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
INVENTOR(S) Seth M. Kiefer (Kansas City, Missouri);  Phillip C. Davis (Independence, Missouri)
ABSTRACT A caul for debulking a composite part broadly includes opposing first and second surfaces, a plurality of through-holes, and a coating. The first surface may have a curvature complementary to a shape of the composite part. The through-holes pass through the caul from the first surface to the second surface. The coating may be a chemically inert material to ensure the caul does not affect the composite part. The caul is configured to be positioned against the composite part for debulking. The caul may be made out of silicone rubber or any other suitable material and may be reusable.
FILED Thursday, July 16, 2020
APPL NO 16/930438
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 33/3842 (20130101)
B29C 70/54 (20130101) Original (OR) Class
B29C 70/342 (20130101)

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2819/00 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 80/00 (20141201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017494 Bara et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) The Board of Trustees of The University of Alabama (Tuscaloosa, Alabama)
ASSIGNEE(S)
INVENTOR(S) Jason Edward Bara (Tuscaloosa, Alabama);  Kathryn Elizabeth O'Harra (Tuscaloosa, Alabama)
ABSTRACT The present disclosure provide synthetic methods for the synthesis of N-substituted vinylidene and alkene compounds in addition to compounds formed from such methods.
FILED Monday, May 17, 2021
APPL NO 17/322332
CURRENT CPC
Heterocyclic Compounds
C07D 403/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017670 WANG et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
Alliance for Sustainable Energy, LLC (ASE)
National Renewable Energy Laboratory (NREL)
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
ASSIGNEE(S)
INVENTOR(S) Chen WANG (Superior, Colorado);  Gregg Tyler BECKHAM (Golden, Colorado);  Nicholas A. RORRER (Golden, Colorado)
ABSTRACT The present disclosure relates to a composition that includes where R includes a reactive end group, R1 includes a first bridging group, 1≤x≤100, and 1≤y≤100.
FILED Friday, July 09, 2021
APPL NO 17/371421
CURRENT CPC
Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 216/36 (20130101) Original (OR) Class
C08F 236/14 (20130101)

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 11/14 (20130101)
C08J 2367/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017992 Stuckman et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FE)
National Energy Technology Laboratory (NETL)
APPLICANT(S) United States Department of Energy (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Mengling Stuckman (Bethel Park, Pennsylvania);  Christina L. Lopano (Bethel Park, Pennsylvania);  Thomas Tarka (Pittsburgh, Pennsylvania)
ABSTRACT The invention provides a method for extracting REEs from ash having the steps of contacting ash with a first acid solution to generate leachate having a pH between approximately 5.0 and approximately 5.5; contacting the ash with a second acid solution to generate leachate having a pH between approximately 2.8 and approximately 3.5; and contacting the ash with a third acid solution to generate leachate having a pH between approximately −0.6 and approximately 0.5. The invention also provides a method for leaching REEs from ash having the steps of: contacting ash with a first amount of acid sufficient to leach Ca and AJ from the ash without leaching REEs; contacting the ash with a second amount of acid sufficient to leach REEs from the ash without leaching Fe and Sc; and contacting ash with a third amount of acid sufficient to leach Fe and Sc from the ash.
FILED Thursday, July 15, 2021
APPL NO 17/376715
CURRENT CPC
Production and Refining of Metals; Pretreatment of Raw Materials
C22B 7/007 (20130101)
C22B 59/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018034 Jiang et al.
FUNDED BY
Department of Energy (DOE)
Battelle Energy Alliance, LLC (BEA)
APPLICANT(S) Battelle Energy Alliance, LLC (Idaho Falls, Idaho)
ASSIGNEE(S)
INVENTOR(S) Junhua Jiang (ldaho Falls, Idaho);  Robert D. Mariani (Idaho Falls, Idaho)
ABSTRACT An electrodeposition system, for additive manufacturing of a three-dimensional structure, includes at least one electrochemical cell. The at least one electrochemical cell includes a receptacle containing an electrolytic bath. At least one nozzle opens from the receptacle toward and proximate a substrate, which is configured as a working electrode of the at least one electrochemical cell. The at least one electrochemical cell also includes a counter electrode disposed in the electrolytic bath. In a method for forming a three-dimensional structure, a metal salt, dissolved in the electrolytic salt, flows through the nozzle to deposit a metal of the metal salt on a surface of the substrate configured as the working electrode. The system may be configured for relative movement between the at least one nozzle and the substrate, enabling additive manufacturing of a three-dimensional structure by electrodeposition.
FILED Tuesday, December 10, 2019
APPL NO 17/309574
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 30/00 (20141201)

Processes for the Electrolytic or Electrophoretic Production of Coatings; Electroforming; Apparatus Therefor
C25D 1/003 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018603 MA et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
Alliance for Sustainable Energy, LLC (ASE)
National Renewable Energy Laboratory (NREL)
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado);  Colorado School of Mines (Golden, Colorado)
ASSIGNEE(S)
INVENTOR(S) Zhiwen MA (Golden, Colorado);  Jeffrey Clayton GIFFORD (Denver, Colorado);  Patrick Gordon DAVENPORT (Boulder, Colorado);  Xingchao WANG (Highlands Ranch, Colorado)
ABSTRACT The present disclosure describes heat exchangers for converting thermal energy stored in solid particles to electricity. Electro-thermal energy storage converts off-peak electricity into heat for thermal energy storage, which may be converted back to electricity, for example during peak-hour power generation. The heat exchanger for converting thermal energy stored in solid particles to electricity enables the conversion of thermal energy into electrical energy for redistribution to the grid. In some embodiments, pressurized fluidized-bed heat exchangers may achieve efficient conversion of thermal energy to electricity by providing direct contact of the solid particles with a gas stream.
FILED Thursday, July 15, 2021
APPL NO 17/376367
CURRENT CPC
Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 1/04 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/32 (20130101)
F05D 2220/76 (20130101)

Heat-exchange Apparatus, Not Provided for in Another Subclass, in Which the Heat-exchange Media Come into Direct Contact Without Chemical Interaction
F28C 3/16 (20130101) Original (OR) Class

Heat-exchange Apparatus, Not Provided for in Another Subclass, in Which the Heat-exchange Media Do Not Come into Direct Contact
F28D 20/0056 (20130101)
F28D 2020/0069 (20130101)
F28D 2020/0078 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020110 Woo et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
National Technology and Engineering Solutions of Sandia, LLC (NTESS)
Sandia National Laboratories (SNL)
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Bryana Lynn Woo (Belen, New Mexico);  Gabriel Carlisle Birch (Albuquerque, New Mexico);  Jaclynn Javonna Stubbs (Albuquerque, New Mexico);  Camron G. Kouhestani (Albuquerque, New Mexico)
ABSTRACT A method and system for temporal frequency analysis for identification of unmanned aircraft systems. The method includes obtaining a sequence of video image frames and providing a pixel from an output frame of the video; generating a fluctuating pixel value vector; examining the fluctuating pixel value vector over a period of time; obtaining the frequency information present in the pixel fluctuations; summing the frequency coefficients for the vectorized pixel values from the fluctuating pixel value vector; obtaining an image representing a two dimensional space based on the summed center frequency coefficients; generating a series of still frames equal to a summation of the center frequency coefficients for pixel variations; and combining the temporal information into spatial locations in a matrix to provide a single image containing the spatial and temporal information present in the sequence of video image frame.
FILED Friday, March 12, 2021
APPL NO 17/200488
CURRENT CPC
Image Data Processing or Generation, in General
G06T 3/00 (20130101)
G06T 3/40 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020203 PAGLIERONI et al.
FUNDED BY
Department of Energy (DOE)
Lawrence Livermore National Laboratory (LLNL)
Lawrence Livermore National Security LLC (LLNS)
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S)
INVENTOR(S) David W. PAGLIERONI (Pleasanton, California);  Harry E. MARTZ, JR. (Livermore, California)
ABSTRACT An automatic threat recognition system and method is disclosed for scanning the x-ray CT image of an article to identify the objects of interest (OOIs) contained within the article, which are otherwise not always quickly apparent or discernable to an individual. The system uses a computer to receive information from two-dimensional (2D) image slices from a reconstructed computed tomography (CT) scan image and to produce a plurality of voxels for each slice of the 2D image. The computer analyzes the voxels to create a likelihood map (LM) representing likelihoods that voxels making up the CT image are associated with a material of interest (MOI). The computer further analyzes the LM to construct neighborhoods of voxels within the LM, and classifies each voxel neighborhood based on its features, thereby decluttering the LM to facilitate the process of connecting voxels of a like MOI together to form segments. The computer classifies each candidate segment based on its features, thereby identifying those segments that correspond to objects of interest.
FILED Tuesday, July 14, 2020
APPL NO 16/928653
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/6256 (20130101)
G06K 9/6267 (20130101)

Image Data Processing or Generation, in General
G06T 7/0002 (20130101)
G06T 15/005 (20130101)
G06T 15/08 (20130101) Original (OR) Class
G06T 2207/10081 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020511 Yin
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) GE Aviation Systems LLC (Grand Rapids, Michigan)
ASSIGNEE(S)
INVENTOR(S) Weijun Yin (Niskayuna, New York)
ABSTRACT A method of manufacturing an insulated conductive component having an electrically conductive element is provided. The method includes applying a first layer of a first material comprising a thermally conductive ceramic on a portion of the conductive element, and applying a second layer of a second material comprising a polymeric resin over the first layer. The method includes curing the conductive element to infuse the second material into the first material to define an electrically insulative, thermally conductive coating on the portion of the electrically conductive element.
FILED Wednesday, July 15, 2020
APPL NO 16/929571
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/185 (20130101)
B05D 3/067 (20130101)
B05D 3/068 (20130101)

Processes for the Electrolytic or Electrophoretic Production of Coatings; Electroforming; Apparatus Therefor
C25D 13/02 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 13/003 (20130101)
H01B 13/16 (20130101) Original (OR) Class
H01B 13/0036 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220021239 MA et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
Alliance for Sustainable Energy, LLC (ASE)
National Renewable Energy Laboratory (NREL)
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado);  Purdue Research Foundation - Office of Technology Commercialization (West Lafayette, Indiana)
ASSIGNEE(S)
INVENTOR(S) Zhiwen MA (Golden, Colorado);  Jeffrey Clayton GIFFORD (Denver, Colorado);  Patrick Gordon DAVENPORT (Boulder, Colorado);  Dening JIA (Lakewood, Colorado);  Jason SCHIRCK (West Lafayette, Indiana);  Aaron MORRIS (West Lafayette, Indiana)
ABSTRACT The disclosure relates to particle heaters for heating solid particles to store electrical energy as thermal energy. Thermal energy storage directly converts off-peak electricity into heat for thermal energy storage, which may be converted back to electricity, for example during peak-hour power generation. The particle heater is an integral part of an electro-thermal energy storage system, as it enables the conversion of electrical energy into thermal energy. As described herein, particle heater designs are described that provide efficient heating of solid particles in an efficient and compact configuration to achieve high energy density and low cost.
FILED Wednesday, July 14, 2021
APPL NO 17/375105
CURRENT CPC
Heat-exchange Apparatus, Not Provided for in Another Subclass, in Which the Heat-exchange Media Do Not Come into Direct Contact
F28D 20/0056 (20130101)
F28D 2020/0004 (20130101)
F28D 2020/0069 (20130101)
F28D 2020/0078 (20130101)
F28D 2020/0082 (20130101)

Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 15/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 20220015342 DUNHAM et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) AUBURN UNIVERSITY (Auburn, Alabama)
ASSIGNEE(S)
INVENTOR(S) Rex A. DUNHAM (Auburn, Alabama);  Zhenkui QIN (Auburn, Alabama);  Guyu QIN (Auburn, Alabama)
ABSTRACT Disclosed are fish with impaired reproductive capacity and methods and compositions for producing the same. The reproductively impaired fish may include catfish, such as Ictalurus punctatus. The disclosed methods may be generally useful for mitigating environmental impact of escaped genetically engineered fish.
FILED Monday, October 11, 2021
APPL NO 17/498110
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0276 (20130101) Original (OR) Class
A01K 2217/00 (20130101)
A01K 2217/075 (20130101)
A01K 2227/40 (20130101)
A01K 2267/02 (20130101)

Peptides
C07K 14/461 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101)
C12N 15/90 (20130101)
C12N 15/102 (20130101)
C12N 15/8509 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220015348 Bizati et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Nitto, Inc. (Lakewood, New Jersey);  Nitto Denko Corporation (Osaka, Japan);  The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Kujtim Bizati (Kingsport, Tennessee);  Yosuke Asamoto (Lakewood, New Jersey);  Junwei J. Zhu (Lincoln, Nebraska);  Hironao Otake (Osaka, Japan);  LIU JEN-CHIEH (Lakewood, New Jersey)
ABSTRACT An adhesive film for attracting and capturing flying insects and method of use are disclosed. The adhesive film includes an adhesive material, an olfactory attractant, a visual attractant and a tackifier. The method of use includes a barrier style trap or a log roll comprised of an adhesive film for attracting and capturing flying insects wound onto a central cylindrical core. The adhesive film may be unwound and attached to a second mounting apparatus. The log roll may be comprised of a continuous sheet of perforated adhesive film which comprises individual sheets wound, which may be removed from the log roll when the adhesiveness of the outer sheet is exhausted, exposing a fresh sheet.
FILED Saturday, October 26, 2019
APPL NO 17/311316
CURRENT CPC
Catching, Trapping or Scaring of Animals; Apparatus for the Destruction of Noxious Animals or Noxious Plants
A01M 1/02 (20130101)
A01M 1/16 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220015367 HART-COOPER et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia);  Method Products, PBC (San Francisco, California)
ASSIGNEE(S)
INVENTOR(S) WILLIAM M. HART-COOPER (RICHMOND, California);  WILLIAM J. ORTS (BURLINGAME, California);  KAJ JOHNSON (SAUSALITO, California);  LAUREN E. LYNN (GLEN GARDNER, New Jersey);  DIANA M. FRANQUIVILLANUEVA (CONCORD, California)
ABSTRACT A self-assembled active agent may be formed by a process including covalently bonding at least a first component molecule and a second component molecule, the two component molecules displaying synergy such that the effective amount of the self-assembled active agent is lower than the sum of the effective amounts of the first component molecule and the second component molecule. The component molecules may be chosen such that the covalent bonding is reversible, for example through a hydrazone bond between an amine and an aldehyde. The active agent may thus have controllable activity such as an antimicrobial agent, a biocide, an antiviral agent, a preservative, an antifouling agent, a disinfectant, or a sensor agent, such as for a particular molecule or for pH.
FILED Wednesday, September 08, 2021
APPL NO 17/469773
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 31/00 (20130101)
A01N 47/44 (20130101) Original (OR) Class
A01N 49/00 (20130101)
A01N 55/08 (20130101)

Acyclic or Carbocyclic Compounds
C07C 279/18 (20130101)
C07C 281/16 (20130101)
C07C 281/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016225 Miller et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States as Represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Lowell A. Miller (Greeley, Colorado);  Jack C. Rhyan (Fort Collins, Colorado)
ABSTRACT The immune response of an animal to a target immunogen may be enhanced by use of an adjuvant which includes low concentrations of killed cells of Mycobacterium avium subspecies avium in combination with mineral oil. The adjuvant may be used in vaccine compositions for the immunization of an animal against any target immunogen and is particularly preferred for use with immunocontraceptive vaccines such as GnRH immunocontraceptive vaccines conjugated with a Blue carrier protein.
FILED Monday, July 20, 2020
APPL NO 16/933157
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/0006 (20130101) Original (OR) Class
A61K 47/62 (20170801)
A61K 2039/54 (20130101)
A61K 2039/521 (20130101)
A61K 2039/552 (20130101)
A61K 2039/55505 (20130101)
A61K 2039/55594 (20130101)

Peptides
C07K 14/59 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017430 Slater et al.
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
Institute of Bioenergy, Climate, and Environment (IBCE)
APPLICANT(S) S2G Ventures Fund II, L.P. (Chicago, Illinois)
ASSIGNEE(S)
INVENTOR(S) Steven C. Slater (Manchester, Washington);  Mauricio Avila-Segura (Madison, Wisconsin);  Margaret F. Phillips (McFarland, Wisconsin);  Lisa Leilani Z. Durand (Madison, Wisconsin);  Gary F. Zimmer (Madison, Wisconsin)
ABSTRACT Provided herein is technology relating to organic fertilizers and particularly, but not exclusively, to organic and/or biodegradable flocculants, methods of preparing organic fertilizers using an organic and/or biodegradable flocculant, and systems for treating water using an organic and/or biodegradable flocculant to prepare an organic fertilizer.
FILED Friday, September 10, 2021
APPL NO 17/472205
CURRENT CPC
Organic Fertilisers Not Covered by Subclasses C05B, C05C, e.g Fertilisers From Waste or Refuse
C05F 17/10 (20200101) Original (OR) Class
C05F 17/40 (20200101)

Mixtures of Fertilisers Covered Individually by Different Subclasses of Class C05; Mixtures of One or More Fertilisers With Materials Not Having a Specific Fertilising Activity, e.g Pesticides, Soil-conditioners, Wetting Agents; Fertilisers Characterised by Their Form
C05G 5/12 (20200201)
C05G 5/45 (20200201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017914 WINTERMANTEL et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) WILLIAM M. WINTERMANTEL (SALINAS, California);  NAVNEET KAUR (SALINAS, California);  WAYNE B. HUNTER (PORT SAINT LUCIE, Florida)
ABSTRACT The present disclosure provides compositions and methods utilizing double strand ribonucleic acid (dsRNA) to control insects, including whiteflies. More particularly, the present invention relates to several specific synthetic dsRNAs that induce RNA interference (RNAi) in the target insects and methods of delivering the dsRNAs to them, such as allowing feeding on plants treated with, or transgenically expressing, the dsRNAs.
FILED Monday, July 26, 2021
APPL NO 17/385172
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 15/8286 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018836 Nitin et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Nitin Nitin (Davis, California);  Mahmoudreza Ovissipour (Davis, California)
ABSTRACT Systems, surrogates, indicators and methods for rapid assessment of sanitation processes are provided. Non-living and non-toxic surrogates applied to a platform or encapsulated in a biological material mounted to a platform are exposed to a sanitation process to be evaluated. Responses to sanitation are measured and quantified using FTIR and chemometrics including principal component analysis (PCA), partial least squares regression (PLSR), loading plots and predictive models. An artificial leaf platform with one or more types of surrogates on one surface and an anchor such as an adhesive film on a second surface is described. Surrogate types include nucleic acid, phage, yeast and algae surrogates. Surrogates may also be attached directly or through a polymer to the platform surface. Surrogates may also be encapsulated or attached to the outside of a biological carrier such as a yeast cell that is free or coupled to the platform.
FILED Thursday, June 10, 2021
APPL NO 17/344202
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/44 (20130101)
G01J 3/108 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/658 (20130101)
G01N 33/56911 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 20220016702 Spradling et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) Millennitek, LLC (Knoxville, Tennessee)
ASSIGNEE(S) Millennitek, LLC (Knoxville, Tennessee)
INVENTOR(S) Andrew M. Spradling (Knoxville, Tennessee);  Lawrence W. Townsend (Knoxville, Tennessee)
ABSTRACT A method of forming tungsten tetraboride, by combining tungsten and boron in a molar ratio of from about 1:6 to about 1:12, respectively, and firing the combined tungsten and boron in the hexagonal boron nitride crucible at a temperature of from about 1600 C to about 2000C, to form tungsten tetraboride.
FILED Wednesday, July 15, 2020
APPL NO 16/947015
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 3/12 (20130101)
B22F 9/04 (20130101) Original (OR) Class
B22F 2009/041 (20130101)
B22F 2201/11 (20130101)
B22F 2201/20 (20130101)
B22F 2202/13 (20130101)
B22F 2302/05 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017243 Barber et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) HONEYWELL INTERNATIONAL INC. (Morris Plains, New Jersey)
ASSIGNEE(S) HONEYWELL INTERNATIONAL INC. (Morris Plains, New Jersey)
INVENTOR(S) Timothy Barber (Litchfield Park, Arizona);  Ken E. Young (Peoria, Arizona);  Timothy Hindle (Peoria, Arizona)
ABSTRACT A launch lock system includes a first portion rigidly coupled to the second portion in a first state and the first portion movable in all directions relative to the second portion in a second state. The launch lock system includes a fastener subassembly coupled to the second portion, and the fastener subassembly is movable relative to the second portion from a first position to a second position. The launch lock system includes at least one pivot arm subassembly having a pivot arm movable between a first position and a second position. The pivot arm is coupled to the first portion in the first position. In the first state, the pivot arm is in the first position and cooperates with the fastener subassembly in the first position, and in the second state, the pivot arm is uncoupled from the first portion and the fastener subassembly.
FILED Thursday, July 16, 2020
APPL NO 16/930990
CURRENT CPC
Cosmonautics; Vehicles or Equipment Therefor
B64G 1/64 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017479 Wohl, JR. et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) United States of America as represented by the Adminstrator of NASA (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Christopher J. Wohl, JR. (Chesapeake, Virginia);  John W. Connell (Yorktown, Virginia);  Emilie J. Siochi (Newport News, Virginia);  Joseph G. Smith, JR. (Smithfield, Virginia)
ABSTRACT Copoly(imide oxetane) materials are disclosed that can exhibit a low surface energy while possessing the mechanical, thermal, chemical and optical properties associated with polyimides. The copoly(imide oxetane)s are prepared using a minor amount of fluorinated oxetane-derived oligomer with sufficient fluorine-containing segments of the copoly(imide oxetane)s migrate to the exterior surface of the polymeric material to yield low surface energies. Thus the coatings and articles of manufacture made with the copoly(imide oxetane)s of this invention are characterized as having an anisotropic fluorine composition. The low surface energies can be achieved with very low content of fluorinated oxetane-derived oligomer. The copolymers of this invention can enhance the viability of polyimides for many applications and may be acceptable where homopolyimide materials have been unacceptable.
FILED Tuesday, September 28, 2021
APPL NO 17/487803
CURRENT CPC
Heterocyclic Compounds
C07D 305/08 (20130101) Original (OR) Class

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 65/16 (20130101)
C08G 65/18 (20130101)
C08G 65/322 (20130101)
C08G 65/33389 (20130101)
C08G 73/02 (20130101)
C08G 73/105 (20130101)
C08G 73/1042 (20130101)

Compositions of Macromolecular Compounds
C08L 67/00 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 179/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017697 Ghose et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The Boeing Company (Chicago, Illinois)
ASSIGNEE(S)
INVENTOR(S) Sayata Ghose (Sammamish, Washington);  Marcus Anthony Belcher (Sammamish, Washington);  John W. Connell (Yorktown, Virginia)
ABSTRACT Compositions including a polyimide and one or more thermally conductive fillers, and compaction rollers for an automated fiber placement machine incorporating the compositions are provided. The polyimide may be a polymeric reaction product of a dianhydride and one or more diamines. The one or more diamines may include a fluorine-containing alkyl ether diamine. The one or more thermally conductive fillers may include one or more of a carbon-based filler, boron nitride, a metal, or combinations thereof. The compositions may have a thermal conductivity of from about 0.2 to about 50 Watts per meter Kelvin (Wm−1 K−1).
FILED Thursday, July 15, 2021
APPL NO 17/377116
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 70/384 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 73/105 (20130101)
C08G 73/1007 (20130101) Original (OR) Class
C08G 73/1078 (20130101)

Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 3/08 (20130101)
C08K 3/38 (20130101)
C08K 3/041 (20170501)
C08K 3/046 (20170501)
C08K 9/02 (20130101)
C08K 2003/085 (20130101)
C08K 2003/385 (20130101)
C08K 2003/0806 (20130101)
C08K 2003/0812 (20130101)
C08K 2003/0862 (20130101)
C08K 2201/001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018060 Subramaniam et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Directorate for Education and Human Resources (EHR)
Division of Human Resource Development (HRD)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Anand Bala Subramaniam (Merced, California);  Joseph Pazzi (Merced, California);  Vaishnavi Girish (Merced, California)
ABSTRACT Methods and compositions for rapid and efficient assembly of fibers coated with lamellar vesicles are provided. Cosmetic and therapeutic uses of vesicle-coated fibers are also provided.
FILED Thursday, November 14, 2019
APPL NO 17/293905
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/1272 (20130101)
A61K 9/1273 (20130101)
A61K 9/1277 (20130101)

Treatment, Not Provided for Elsewhere in Class D06, of Fibres, Threads, Yarns, Fabrics, Feathers or Fibrous Goods Made From Such Materials
D06M 13/203 (20130101)
D06M 15/647 (20130101)
D06M 23/02 (20130101) Original (OR) Class

Pulp Compositions; Preparation Thereof Not Covered by Subclasses D21C or D21D; Impregnating or Coating of Paper; Treatment of Finished Paper Not Covered by Class B31 or Subclass D21G; Paper Not Otherwise Provided for
D21H 19/82 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018741 Mathies et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Richard A. Mathies (Walnut Creek, California);  Anna Butterworth (Berkeley, California);  Matin Golozar (Berkeley, California);  Jeremy McCauley (Martinez, California);  James Stephen Oliver New (London, United Kingdom)
ABSTRACT In various embodiments a capture surface for capturing high velocity and hypervelocity dust and ice particles is provided. In certain embodiments the capture surface is comprised of a soft metal that is chosen to optimize particle capture efficiency, to minimize thermal degradation of chemicals and biochemical in the particles, and to present the captured particles to an analyzer for chemical and biochemical analysis of the particles and their contents. In various embodiments capture chambers comprising one or more such capture surfaces are provided as well as methods of use thereof.
FILED Monday, December 02, 2019
APPL NO 17/298502
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 1/00 (20130101)
B01L 3/52 (20130101)
B01L 3/567 (20130101)
B01L 3/502715 (20130101)
B01L 2200/16 (20130101)
B01L 2300/043 (20130101)
B01L 2300/045 (20130101)
B01L 2300/088 (20130101)
B01L 2300/0883 (20130101)
B01L 2400/06 (20130101)
B01L 2400/0421 (20130101)
B01L 2400/0487 (20130101)

Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 47/00 (20130101)

Cosmonautics; Vehicles or Equipment Therefor
B64G 1/66 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/2273 (20130101) Original (OR) Class
G01N 1/4055 (20130101)
G01N 33/6809 (20130101)
G01N 35/1095 (20130101)
G01N 2001/2279 (20130101)
G01N 2001/4061 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 20220017884 Pillai et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Segaran Pillai (Laurel, Maryland);  Linda Weigel (Decatur, Georgia);  Bernard Quigley (Atlanta, Georgia);  David R. Hodge (Washington, District of Columbia)
ABSTRACT Novel Bacillus lysin proteins have been identified and characterized. Methods to detect the presence or absence of bacteria in a sample, methods for lysing bacteria, and methods for decontaminating or disinfecting areas contaminated with bacteria that utilize these lysin proteins have also been developed.
FILED Friday, October 01, 2021
APPL NO 17/491845
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 47/44 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/12 (20130101)
A61K 38/47 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/2405 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/689 (20130101)

Enzymes
C12Y 302/01 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220018738 Cho
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Inho Cho (Egg Harbor Township, New Jersey)
ABSTRACT In an example, a thermal extraction apparatus includes: a housing having a gas inlet and a gas outlet to receive a gas flow through the housing from the gas inlet to the gas outlet, and a side opening to receive a sample collector, having a sample collector adsorbent containing a vapor sample, into a sample collector location; a pump to generate the gas flow; a heater to heat the sample collector adsorbent of the sample collector to a temperature sufficient to release the vapor sample; a thermal desorption (TD) tube connected with the gas outlet of the housing to receive the gas flow downstream of the sample collector and collect the vapor sample released from the sample collector adsorbent of the sample collector; and a cooling member in heat exchange with the TD tube to cool the TD tube.
FILED Friday, January 29, 2021
APPL NO 17/162984
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/44 (20130101)
G01N 1/2214 (20130101) Original (OR) Class
G01N 1/2247 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220019649 Boyd et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Daniel A. Boyd (Arlington, Virginia);  Kelli L. Biegger (McLean, Virginia);  Chang Ellison (Arlington, Virginia);  Brandon P. Gutierrez (Burke, Virginia);  Jason Lim (Alexandria, Virginia);  William Washington (North Potomac, Maryland)
ABSTRACT An online host method to verify hosted information associated with a user includes establishing, by the online host serving as a relying party system (RPS), a secure connection between the RPS and a user mobile-identification-credential device (UMD). The RPS sends a mobile identification credential (MIC) user information request to the UMD, via the secure connection, seeking release of MIC user information (official information). The RPS obtains from authorizing party system (APS) verification of the MIC user information received in response to the MIC user information request. The RPS stores the MIC user information as hosted information pertaining to the user. The RPS designates the hosted information as base truth information representing the user.
FILED Friday, February 19, 2021
APPL NO 17/180421
CURRENT CPC
Electric Digital Data Processing
G06F 21/32 (20130101) Original (OR) Class
G06F 2221/2133 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00288 (20130101)
G06K 9/00906 (20130101)
G06K 9/6202 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 20220016224 Wyss-Coray et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Anton Wyss-Coray (Palo Alto, California);  Joseph M. Castellano (Tuckahoe, New York)
ABSTRACT Methods of treating an adult mammal for an aging-associated condition are provided. Aspects of the methods include enhancing a TIMP activity, e.g., a TIMP2 activity, in the mammal in a manner sufficient to treat the adult mammal for the aging-associated condition. Also provided are compositions for use in practicing methods of the invention. A variety of aging-associated conditions may be treated by practice of the methods, which conditions include cognitive impairments.
FILED Friday, October 08, 2021
APPL NO 17/496986
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/55 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/28 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220016425 Urbin
FUNDED BY
Department of Veterans Affairs (DVA)
APPLICANT(S) United States Government As Represented By The Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Michael A. Urbin (Pittsburgh, Pennsylvania)
ABSTRACT A method of acutely activating the noradrenergic systems in a subject can comprise applying one or more electrical pulses to an ear canal (e.g., the left ear canal) of the subject, wherein the one or more electrical pulses are sufficient to acutely activate the noradrenergic system of the subject. Apparatuses and systems for applying one or more electrical pulses to an ear canal are also disclosed.
FILED Friday, July 16, 2021
APPL NO 17/378098
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/0456 (20130101)
A61N 1/0484 (20130101)
A61N 1/36036 (20170801) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220017609 Hansen et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Yale University (New Haven, Connecticut);  The Regents of the University of California (Oakland, California);  The United States Government represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) James E. Hansen (Guilford, Connecticut);  Peter M. Glazer (Guilford, Connecticut);  Richard H. Weisbart (Los Angeles, California);  Robert N. Nishimura (Santa Monica, California);  Grace Chan (Monterey Park, California)
ABSTRACT Antibodies that penetrate cell nuclei and inhibit DNA repair or interfere with DNA metabolism are provided for treatment of cancer (both directly and by sensitizing cancer cells to DNA-damaging treatments) or inhibiting or preventing viral infection, proliferation or metabolism. The method involves treating cells with a composition containing cell-penetrating anti-DNA antibodies or derivatives thereof, alone or in combination with treatment that induces DNA damage such as DNA-damaging chemotherapy or radiation. The impact of the cell-penetrating anti-DNA antibodies or derivatives thereof is potentiated in cancer cells that are deficient in DNA repair, and the cell-penetrating anti-DNA antibodies or derivatives thereof are synthetically lethal to cancer cells with DNA repair deficiencies.
FILED Friday, March 05, 2021
APPL NO 17/193933
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/337 (20130101)
A61K 31/475 (20130101)
A61K 31/513 (20130101)
A61K 31/704 (20130101)
A61K 31/7068 (20130101)
A61K 33/243 (20190101)
A61K 39/39558 (20130101)
A61K 45/06 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/18 (20130101) Original (OR) Class
C07K 16/44 (20130101)
C07K 2317/73 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 20220018914 Holloway et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Government of the United States of America, as represented by the Secretary of Commerce (Gaithersburg, Maryland)
ASSIGNEE(S)
INVENTOR(S) Christopher Lee Holloway (Boulder, Colorado);  John Edward Kitching (Boulder, Colorado);  Alexandra Brae Artusio-Glimpse (Boulder, Colorado);  Vladimir Anatolyevich Aksyuk (Gaithersburg, Maryland);  Matthew Thomas Simons (Lafayette, Colorado);  Omar Daniel Lopez (Gaithersburg, Maryland)
ABSTRACT An atomic vapor cell for performing RF measurements includes: a first optical window of transparent nonconducting material free of electrically conductive materials; an intermediate frame of transparent nonconducting material free of electrically conductive materials; a second optical window disposed on the intermediate frame and including transparent nonconducting material free of electrically conductive materials to minimize distortion of radiofrequency fields by the windows and frame; and a cell aperture, wherein the atomic vapor cell is hermetically sealed by bonding between the first optical window and the second optical window to the intermediate frame.
FILED Tuesday, July 13, 2021
APPL NO 17/374537
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/26 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20220020979 Loveness et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Amprius, Inc. (Fremont, California)
ASSIGNEE(S)
INVENTOR(S) Ghyrn E. Loveness (Mountain View, California);  William S. Delhagen (San Francisco, California);  Rainer J. Fasching (Mill Valley, California);  Song Han (Foster City, California);  Zuqin Liu (Sunnyvale, California)
ABSTRACT Provided are examples of electrochemically active electrode materials, electrodes using such materials, and methods of manufacturing such electrodes. Electrochemically active electrode materials may include a high surface area template containing a metal silicide and a layer of high capacity active material deposited over the template. The template may serve as a mechanical support for the active material and/or an electrical conductor between the active material and, for example, a substrate. Due to the high surface area of the template, even a thin layer of the active material can provide sufficient active material loading and corresponding battery capacity. As such, a thickness of the layer may be maintained below the fracture threshold of the active material used and preserve its structural integrity during battery cycling.
FILED Tuesday, May 18, 2021
APPL NO 17/323575
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/38 (20130101)
H01M 4/58 (20130101)
H01M 4/66 (20130101)
H01M 4/75 (20130101)
H01M 4/134 (20130101)
H01M 4/136 (20130101)
H01M 4/366 (20130101) Original (OR) Class
H01M 4/386 (20130101)
H01M 4/0428 (20130101)
H01M 4/587 (20130101)
H01M 4/661 (20130101)
H01M 4/667 (20130101)
H01M 4/1395 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49108 (20150115)
Y10T 29/49115 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Transportation (USDOT) 

US 20220021441 Zhang et al.
FUNDED BY
Department of Transportation (USDOT)
Federal Aviation Administration (FAA)
APPLICANT(S) The Board of Regents of the University of Oklahoma (Norman, Oklahoma)
ASSIGNEE(S)
INVENTOR(S) Yan Zhang (Norman, Oklahoma);  Hernan A. Suarez Montalvo (Norman, Oklahoma);  Sudantha Perera (Broomfield, Colorado)
ABSTRACT An instrument landing system comprises: a wideband antenna configured to receive signals in a VHF band; and a receiver coupled to the wideband antenna and configured to implement SDR functions to analyze the signals for a flight inspection. A UAS comprises: an instrument landing system comprising: a wideband antenna configured to receive signals in a VHF band; and a receiver coupled to the wideband antenna and configured to implement SDR functions to analyze the signals for a flight inspection. A method comprises: receiving, using a wideband antenna, signals in a VHF band; and implementing, using a receiver coupled to the wideband antenna, SDR functions to analyze the signals for a flight inspection.
FILED Tuesday, July 20, 2021
APPL NO 17/380960
CURRENT CPC
Transmission
H04B 1/16 (20130101)
H04B 7/18506 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of the Interior (DOI) 

US 20220017385 YIP et al.
FUNDED BY
Department of the Interior (DOI)
United States Bureau of Reclamation (USBR)
APPLICANT(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
ASSIGNEE(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
INVENTOR(S) Ngai Yin YIP (Summit, New Jersey);  Chanhee BOO (New York, New York);  Kinnari SHAH (New York, New York);  Ian BILLINGE (New York, New York);  Robert Winton (New York, New York);  Eliza DACH (New York, New York)
ABSTRACT Systems and methods of performing temperature swing solvent extraction (TSSE) descaling of produced water and desalination of high-salinity brines, e.g., those having a total dissolved solids (TDS) greater than about 250,000 ppm are capable of producing descaled water products including less than about 5% weight percent TDS. The brine/produced water feedstreams and combined with a solvent having temperature-dependent water solubility at a temperature TL. Water is extracted from the feedstream into the solvent to form a water-in-solvent extract component and a raffinate component, from which a solid phase can be precipitated as more water is portioned in the solvent and basicity increases. Heating of the water-in-solvent extract component reduces the solubility of the water therein, producing a biphasic mixture of dewatered solvent and descaled water that can be separated. Because these systems and methods do not require a phase change of water, these products are achieved with significantly higher energy efficiencies when compared to evaporation-based thermal methods.
FILED Monday, May 18, 2020
APPL NO 17/346915
CURRENT CPC
Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/042 (20130101)
C02F 1/265 (20130101) Original (OR) Class
C02F 2209/02 (20130101)
C02F 2209/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Environmental Protection Agency (EPA) 

US 20220016178 Thomson et al.
FUNDED BY
Environmental Protection Agency (EPA)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S)
INVENTOR(S) James A. Thomson (Madison, Wisconsin);  Srikumar Sengupta (Madison, Wisconsin)
ABSTRACT This disclosure relates generally to new methods of maintaining the expression of hepatic genes in human hepatocytes and method for maintaining the functional hepatic enzyme activity of primary hepatocytes in culture. The disclosure also encompasses new methods of deriving a population of pure hepatocytes without selecting or sorting the cells from the cultured pluripotent cells.
FILED Tuesday, July 27, 2021
APPL NO 17/443786
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/407 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/00 (20130101)
C12N 5/067 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/02 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Geospatial Intelligence Agency (NGA) 

US 20220020169 Warnaar
FUNDED BY
National Geospatial Intelligence Agency (NGA)
APPLICANT(S) Applied Research Associates, Inc. (Albuquerque, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Dirk B. Warnaar (Raleigh, North Carolina)
ABSTRACT Systems and techniques for determining a list of geographic location candidates from an image of an environment are described. Open source data indicative of the earth's surface may be obtained and combined into grids to create region data to gain a representation of the earth's surface within each grid cell. An image of an environment may be obtained from an unknown camera. Image characteristics may be compared to the region data to determine error between the image characteristics and projections of the region data. A list of lowest error geographic location candidates may be determined and provided to the user.
FILED Thursday, September 30, 2021
APPL NO 17/490578
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/04 (20130101)

Image Data Processing or Generation, in General
G06T 7/73 (20170101) Original (OR) Class
G06T 7/80 (20170101)
G06T 2207/30244 (20130101)

Pictorial Communication, e.g Television
H04N 13/111 (20180501)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Security Agency (NSA) 

US 20220021459 Kurczveil et al.
FUNDED BY
National Security Agency (NSA)
APPLICANT(S) Hewlett Packard Enterprise Development LP (Houston, Texas)
ASSIGNEE(S)
INVENTOR(S) Geza Kurczveil (Santa Barbara, California);  Di Liang (Santa Barbara, California);  Sudharsanan Srinivasan (Santa Barbara, California);  Raymond G. Beausoleil (Seattle, Washington)
ABSTRACT Examples herein relate to optical systems. In particular, implementations herein relate to an optical system including an optical transmitter configured to transmit optical signals. The optical transmitter includes a first optical source and a second optical source coupled to the first optical source and injection seeded by the first optical source. The optical transmitter further includes an output coupler, the second optical source coupled to the optical coupler via an output waveguide and configured to emit light having multiple different wavelengths through the output waveguide. In some implementations, the second optical source is self-injection seeded.
FILED Thursday, July 16, 2020
APPL NO 16/947056
CURRENT CPC
Transmission
H04B 10/506 (20130101) Original (OR) Class
H04B 10/5057 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Non-Profit Organization (NPO) 

US 20220016406 So et al.
FUNDED BY
Non-Profit Organization (NPO)
California Institute for Regenerative Medicine (CIRM)
APPLICANT(S) ViaCyte, Inc. (San Diego, California)
ASSIGNEE(S) ViaCyte, Inc. (San Diego, California)
INVENTOR(S) Vincent So (San Diego, California);  Laura Martinson (San Diego, California);  Chad Green (San Diego, California);  Michael Scott (San Diego, California);  Mario Zamarripa (San Diego, California)
ABSTRACT Disclosed herein are implantable 3-dimensional large capacity device assemblies, specifically, large capacity device assemblies for encapsulating pancreatic progenitor cells for treatment of diabetes.
FILED Wednesday, July 28, 2021
APPL NO 17/387855
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/022 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 31/002 (20130101) Original (OR) Class
A61M 2202/09 (20130101)
A61M 2205/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Office of the Director of National Intelligence (ODNI) 

US 20220021391 PASANDI et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California)
ASSIGNEE(S)
INVENTOR(S) Ghasem PASANDI (Los Angeles, California);  Massoud PEDRAM (Beverly Hills, California)
ABSTRACT An SFQ circuit system includes at least one SFQ block having a plurality of SFQ logic gates. Characteristically, at least a portion of the SFQ logic gates are arranged in series. The SFQ circuit system includes a timing system configured to provide a first set of inputs and collect a first set of outputs of the at least one SFQ block at a rate defined by a slow clock frequency while the SFQ logic gates are clocked at a fast clock frequency. Advantageously, the rate is sufficiently slow to allow the first set of inputs to propagate through all levels of the SFQ logic gates to produce the first set of outputs of the at least one SFQ block without colliding with a second set of inputs to the at least one SFQ block.
FILED Monday, April 05, 2021
APPL NO 17/221998
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101)

Pulse Technique
H03K 19/20 (20130101)
H03K 19/096 (20130101)
H03K 19/195 (20130101) Original (OR) Class
H03K 19/17744 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

How To Use This Page 

THE FEDINVENT PATENT APPLICATION DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Thursday, January 20, 2022.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week's taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer-funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract is presented as it appears on the patent.

FILED
The date the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that the more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2021/details-patents-20210427.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital